Zaunders J; Munier CML; McGuire H; Law H; Howe A; Xu Y; de St Groth BF; Schofield P; Christ D; Milner B; Obeid S; Dyer WB; Saksena NK; Kelleher AD, 2020, 'Mapping the extent of heterogeneity of human CCR5+ CD4 T-cells in peripheral blood and lymph nodes.',
AIDS,
http://dx.doi.org/10.1097/QAD.00000000000025032020
Cook L; Munier CML; Seddiki N; Hardy MY; Anderson RP; Zaunders J; Tye-Din JA; Kelleher AD; van Bockel D, 2020, 'Circulating gluten-specific, but not CMV-specific, CD39
+ regulatory T cells have an oligoclonal TCR repertoire',
Clinical and Translational Immunology, vol. 9,
http://dx.doi.org/10.1002/cti2.10962020
Hey-Nguyen WJ; Bailey M; Xu Y; Suzuki K; Van Bockel D; Finlayson R; Leigh Brown A; Carr A; Cooper DA; Kelleher AD; Koelsch KK; Zaunders JJ, 2019, 'HIV-1 DNA Is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen Exposure',
AIDS Research and Human Retroviruses, vol. 35, pp. 112 - 120,
http://dx.doi.org/10.1089/aid.2018.02352019
Khanna M; Jackson RJ; Alcantara S; Amarasena TH; Li Z; Kelleher AD; Kent SJ; Ranasinghe C, 2019, 'Mucosal and systemic SIV-specific cytotoxic CD4
+ T cell hierarchy in protection following intranasal/intramuscular recombinant pox-viral vaccination of pigtail macaques',
Scientific Reports, vol. 9, pp. 5661,
http://dx.doi.org/10.1038/s41598-019-41506-52019
Di Giallonardo F; Pinto AN; Keen P; Shaik A; Carrera A; Salem H; Telfer B; Cooper C; Price K; Selvey C; Holden J; Bachmann N; Lee FJ; Dwyer DE; Duchêne S; Holmes EC; Grulich AE; Kelleher AD, 2019, 'Limited sustained local transmission of HIV-1 CRF01_AE in New South Wales, Australia',
Viruses, vol. 11,
http://dx.doi.org/10.3390/v110504822019
Juno JA; Wragg KM; Kristensen AB; Lee WS; Selva KJ; Van Der Sluis RM; Kelleher AD; Bavinton BR; Grulich AE; Lewin SR; Kent SJ; Parsons MS, 2019, 'Modulation of the CCR5 Receptor/Ligand Axis by Seminal Plasma and the Utility of in Vitro versus in Vivo Models',
Journal of Virology, vol. 93,
http://dx.doi.org/10.1128/JVI.00242-192019
Cahn P; Madero JS; Arribas JR; Antinori A; Ortiz R; Clarke AE; Hung CC; Rockstroh JK; Girard PM; Sievers J; Man C; Currie A; Underwood M; Tenorio AR; Pappa K; Wynne B; Fettiplace A; Gartland M; Aboud M; Smith K; Cassetti L; David D; Figueras L; Losso M; Lopardo G; Lupo S; Porteiro N; Sánchez M; Bloch M; Cooper D; Finlayson R; Kelleher A; Koh K; Lewis D; McMahon J; Moore R; Roth N; Shields M; De Wit S; Florence E; Goffard JC; Demeester R; Lacor P; Vandercam B; Vandekerckhove L; Angel J; Baril JG; Conway B; De Pokomandy A; Szabo J; Walmsley S; Bouchaud O; Chidiac C; Delobel P; Goujard C; Katlama C; Molina JM; Pialoux G; Philibert P; Bogner J; Esser S; Krznaric I; Lehmann C; Spinner C; Stellbrink HJ; Stephan C; Stoehr A; Barchi E; Caramello P; Castelli F; Cattelan AM; D'Arminio Monforte A; Di Biagio A; Di Perri G; Gori A; Maggiolo F; Menzaghi B; Migliorino G; Mussini C; Penco G; Puoti M; Rizzardini G; Gulminetti R; Lazzarin A; Quirino T; Sighinolfi L; Viale P; Amaya Tapia G; Andrade Villanueva J; Granados Reyes ER; Perez Rios A; Santoscoy Gomez M; Den Hollander J; Rijnders B; Hidalgo JA; Hercilla Vasquez L; Illescas L; Olczak A; Mansinho K; Correia Pacheco PP, 2019, 'Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials',
The Lancet, vol. 393, pp. 143 - 155,
http://dx.doi.org/10.1016/S0140-6736(18)32462-02019
Davenport MP; Khoury DS; Cromer D; Lewin SR; Kelleher AD; Kent SJ, 2019, 'Functional cure of HIV: the scale of the challenge',
Nature Reviews Immunology, vol. 19, pp. 45 - 54,
http://dx.doi.org/10.1038/s41577-018-0085-42019
Selva KJ; Bavinton BR; Grulich AE; Pazgier M; Kelleher AD; Kent SJ; Parsons MS, 2019, 'Impact of HIV-1 viremia or sexually transmitted infection on semen-derived anti-HIV-1 antibodies and the immunosuppressive capacity of seminal plasma',
European Journal of Immunology, vol. 49, pp. 2255 - 2258,
http://dx.doi.org/10.1002/eji.2018480552019
Hemelaar J; Elangovan R; Yun J; Dickson-Tetteh L; Fleminger I; Kirtley S; Williams B; Gouws-Williams E; Ghys PD; Abimiku AG; Agwale S; Archibald C; Avidor B; Barbás MG; Barre-Sinoussi F; Barugahare B; Belabbes EH; Bertagnolio S; Birx D; Bobkov AF; Brandful J; Bredell H; Brennan CA; Brooks J; Bruckova M; Buonaguro L; Buonaguro F; Buttò S; Buve A; Campbell M; Carr J; Carrera A; Carrillo MG; Celum C; Chaplin B; Charles M; Chatzidimitriou D; Chen Z; Chijiwa K; Cooper D; Cunningham P; Dagnra A; de Gascun CF; Del Amo J; Delgado E; Dietrich U; Dwyer D; Ellenberger D; Ensoli B; Essex M; Gao F; Fleury H; Fonjungo PN; Foulongne V; Gadkari DA; García F; Garsia R; Gershy-Damet GM; Glynn JR; Goodall R; Grossman Z; Lindenmeyer-Guimarães M; Hahn B; Hamers RL; Hamouda O; Handema R; He X; Herbeck J; Ho DD; Holguin A; Hosseinipour M; Hunt G; Ito M; Bel Hadj Kacem MA; Kahle E; Kaleebu PK; Kalish M; Kamarulzaman A; Kang C; Kanki P; Karamov E; Karasi JC; Kayitenkore K; Kelleher T; Kitayaporn D; Kostrikis LG; Kucherer C; Lara C; Leitner T; Liitsola K; Lingappa J; Linka M; Lorenzana de Rivera I; Lukashov V; Maayan S; Mayr L; McCutchan F; Meda N; Menu E; Mhalu F, 2019, 'Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis',
The Lancet Infectious Diseases, vol. 19, pp. 143 - 155,
http://dx.doi.org/10.1016/S1473-3099(18)30647-92019
Van Santen DK; Van Der Helm JJ; Touloumi G; Pantazis N; Muga R; Gunsenheimer-Bartmeyer B; Gill MJ; Sanders E; Kelleher A; Zangerle R; Porter K; Prins M; Geskus RB, 2019, 'Effect of incident hepatitis C infection on CD4 cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort',
AIDS, vol. 33, pp. 327 - 337,
http://dx.doi.org/10.1097/QAD.00000000000020402019
Bavinton BR; Prestage GP; Jin F; Phanuphak N; Grinsztejn B; Fairley CK; Baker D; Hoy J; Templeton DJ; Tee BK; Kelleher A; Grulich AE, 2019, 'Strategies used by gay male HIV serodiscordant couples to reduce the risk of HIV transmission from anal intercourse in three countries',
Journal of the International AIDS Society, vol. 22, pp. e25277,
http://dx.doi.org/10.1002/jia2.252772019
Phetsouphanh C; Aldridge D; Marchi E; Munier CML; Meyerowitz J; Murray L; Van Vuuren C; Goedhals D; Fidler S; Kelleher A; Klenerman P; Frater J, 2019, 'Maintenance of functional CD57+ cytolytic CD4+ T cells in HIV+ elite controllers',
Frontiers in Immunology, vol. 10,
http://dx.doi.org/10.3389/fimmu.2019.018442019
Vaccher SJ; Marzinke MA; Templeton DJ; Haire BG; Ryder N; McNulty A; Foster R; Grulich AE; Zablotska IB; Bloch M; Carr A; Cheung C; Gianacas C; Guy R; Holt M; Kaldor J; Mackie B; Mayer K; McAllister J; Murphy D; Ooi C; Pell C; Poynten IM; Prestage G; de Wit J; Wright E; Callander D; Cooper D; Crooks L; Duck T; Holden J; Keen P; Kelleher A; Mitchell J; Price K; Selvey C; Schmidt HM; Telfer B; Whittaker B; Wilson D, 2019, 'Predictors of Daily Adherence to HIV Pre-exposure Prophylaxis in Gay/Bisexual Men in the PRELUDE Demonstration Project',
AIDS and Behavior, vol. 23, pp. 1287 - 1296,
http://dx.doi.org/10.1007/s10461-018-2353-52019
Gossez M; Martin GE; Pace M; Ramjee G; Premraj A; Kaleebu P; Rees H; Inshaw J; Stöhr W; Meyerowitz J; Hopkins E; Jones M; Hurst J; Porter K; Babiker A; Fidler S; Frater J, 2019, 'Virological remission after antiretroviral therapy interruption in female African HIV seroconverters',
AIDS, vol. 33, pp. 185 - 197,
http://dx.doi.org/10.1097/QAD.00000000000020442019
Bavinton BR; Pinto AN; Phanuphak N; Grinsztejn B; Prestage GP; Zablotska-Manos IB; Jin F; Fairley CK; Moore R; Roth N; Bloch M; Pell C; McNulty AM; Baker D; Hoy J; Tee BK; Templeton DJ; Cooper DA; Emery S; Kelleher A; Grulich AE; Jin F; Bavinton BR; Cooper DA; Fairley CK; Wilson D; Koelsch KK; Triffitt K; Doong N; Baker D; McNulty A; Pell C; Hoy J; Tee BK; Moore R; Orth D; Pinto AN, 2018, 'Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study',
The Lancet HIV, vol. 5, pp. e438 - e447,
http://dx.doi.org/10.1016/S2352-3018(18)30132-22018
Soodla P; Simmons R; Huik K; Pauskar M; Jõgeda EL; Rajasaar H; Kallaste E; Maimets M; Avi R; Murphy G; Porter K; Lutsar I; Del Amo J; Meyer L; Bucher HC; Chêne G; Hamouda O; Pillay D; Prins M; Rosinska M; Sabin C; Touloumi G; Olson A; Cartier A; Fradette L; Walker S; Babiker A; De Luca A; Fisher M; Muga R; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Dabis F; Thiebaut R; Costagliola D; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Boufassa F; Meixenberger K; Bannert N; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Pantazis N; Katsarou O; Rezza G; Dorrucci M; Monforte ADA; Geskus R; van der Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AMB; Rosinska M; Tor J; de Olalla PG; Cayla J; Moreno S; Monge S; del Romero J; Pérez-Hoyos S; Sönnerborg A; Günthard H; Scherrer A; Malyuta R; Johnson A; Phillips A; Morrison C; Price MA; Giaquinto C; Grarup J; Kirk O; Bailey H; Volny Anne A; Panteleev A; Thorne C; Aboulker JP; Albert J; Asandi S; De Wit S; Reiss P; Gatell J; Karpov I; Ledergerber B; Møller C; Rakhmanova A; Rockstroh J, 2018, 'HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay',
HIV Medicine, vol. 19, pp. 33 - 41,
http://dx.doi.org/10.1111/hiv.125352018
Pinto AN; Hawke K; Castley A; Chibo D; Giallonardo FD; Cooper C; Sawleshwarkar S; Kelleher A; Dwyer DE, 2018, 'HIV-1 subtype diversity, transmitted drug resistance and phylogenetics in Australia',
Future Virology, vol. 13, pp. 575 - 584,
http://dx.doi.org/10.2217/fvl-2018-00312018
Keen P; Gray RT; Telfer B; Guy R; Schmidt H; Whittaker B; Holden J; Holt M; Kelleher A; Wilson D; Callander D; Cooper DA; Prestage GP; Selvey C; Grulich A, 2018, 'The 2016 HIV diagnosis and care cascade in New South Wales, Australia: meeting the UNAIDS 90-90-90 targets',
Journal of the International AIDS Society, vol. 21, pp. e25109 - e25109,
http://dx.doi.org/10.1002/jia2.251092018
Stirrup OT; Copas AJ; Phillips AN; Gill MJ; Geskus RB; Touloumi G; Young J; Bucher HC; Babiker AG; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Lutsar I; Chêne G; Dabis F; Thiebaut R; Costagliola D; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Meyer L; Boufassa F; Hamouda O; Meixenberger K; Bannert N; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Pantazis N; Katsarou O; Rezza G; Dorrucci M; Monforte A; Luca A; Prins M; Geskus R; Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AM; Rosinska M; Muga R; Tor J; Olalla P; Cayla J; Moreno S; Monge S; Amo J; Romero J; Pérez-Hoyos S; Sönnerborg A; Bucher C; Günthard H; Scherrer A; Malyuta R; Murphy G; Porter K; Johnson A; Babiker A; Pillay D; Morrison C; Salata R; Mugerwa R; Chipato T; Price MA; Gilmour J; Kamali A; Karita E, 2018, 'Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion',
HIV Medicine, vol. 19, pp. 184 - 194,
http://dx.doi.org/10.1111/hiv.125672018
Worley MJ; Fei K; Lopez-Denman AJ; Kelleher AD; Kent SJ; Chung AW, 2018, 'Neutrophils mediate HIV-specific antibody-dependent phagocytosis and ADCC',
Journal of Immunological Methods, vol. 457, pp. 41 - 52,
http://dx.doi.org/10.1016/j.jim.2018.03.0072018
MacIntyre CR; Costantino V; Chen X; Segelov E; Chughtai AA; Kelleher A; Kunasekaran M; Lane JM, 2018, 'Influence of population immunosuppression and past vaccination on smallpox reemergence',
Emerging Infectious Diseases, vol. 24, pp. 646 - 653,
http://dx.doi.org/10.3201/eid2404.1712332018
Kent SJ; Hough S; Kelleher AD; Law MG; Hutchinson J; Catalfarmo M; van Bockel D; Lane C; Baker JV; Emery S, 2018, 'Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial',
The Lancet HIV, vol. 5, pp. e553 - e559,
http://dx.doi.org/10.1016/S2352-3018(18)30214-52018
Jamil MS; McManus H; Callander D; Prestage G; Ali H; O’Connor CC; Chen M; McNulty AM; Knight V; Duck T; Keen P; Gray J; Medland N; Hellard M; Lewis DA; Grulich AE; Kaldor JM; Fairley CK; Donovan B; Guy RJ; Marshall L; Wilson D; Dickson B; Kong M; Smith LW; Cooper D; Selvey C; Holden J; Crooks L; Cooper C; Price K; de Wit J; Kelleher A; Mitchell J; Schmidt HM; Telfer B; Whittaker B, 2018, 'Understanding the Targeting and Uptake of HIV Testing Among Gay and Bisexual Men Attending Sexual Health Clinics',
AIDS and Behavior, vol. 22, pp. 513 - 521,
http://dx.doi.org/10.1007/s10461-017-2012-22018
Pett SL; Amin J; Horban A; Andrade-Villanueva J; Losso M; Porteiro N; Madero JS; Belloso W; Tu E; Silk D; Kelleher A; Harrigan R; Clark A; Sugiura W; Wolff M; Gill J; Gatell J; Clarke A; Ruxrungtham K; Prazuck T; Kaiser R; Woolley I; Alberto Arnaiz J; Cooper D; Rockstroh JK; Mallon P; Emery S; Fisher M; Rockstroh J; Stellbrink J; Merlin K; Yeung J; Fsadni B; Marks K; Suzuki K; Rismanto N; Salomon H; Rubio AE; Chibo D; Birch C; Swenson L; Chan D; Berg T; Obermeier M; Schuelter E; Aragon SS; Luebke N; Coughlan S; Dean J; Iwatani Y; Teran GR; Avila S; Sirivichayakul S; Naphassanant M; Ubolyam S; Kaye S; Land S; Walker S; Haubrich R; DeJesus E; Berthon-Jones N; Espinosa N; Courtney-Vega K; Absar N; Haskelberg H; Robson R; Donaldson A; Guelman D; Gambardella L; Valdovinos M; Arnaiz J; Beleta H; Ramos N; Targa M; Späth B; Boesecke C; Engelhardt A; Perry N; Beckthold B; Drummond F; Lefevre E; Corr S; Grant C; Lupo S; Peroni L; Sanchez M; De Paz Sierra M; Viloria G; Parlante A; Bissio E; Luchetti P; Confalonieri V; Warley E; Vieni I; Vilas C; Zarate A; Mayer G; Elliot J; Hagenauer M; Kelley M, 2018, 'Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study',
HIV Medicine, vol. 19, pp. 65 - 71,
http://dx.doi.org/10.1111/hiv.125322018
Philpot SP; Prestage G; Ellard J; Grulich AE; Bavinton BR, 2018, 'How do gay serodiscordant couples in Sydney, Australia negotiate undetectable viral load for HIV prevention?',
AIDS and Behavior, vol. 22, pp. 3981 - 3990,
http://dx.doi.org/10.1007/s10461-018-2247-62018
Pinto AN; Grey P; Shaik A; Cooper DA; Kelleher AD; Petoumenos K, 2018, 'Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality',
AIDS Research and Human Retroviruses, vol. 34, pp. 936 - 941,
http://dx.doi.org/10.1089/aid.2017.02842018
Deenick EK; Morey A; Danta M; Emmett L; Fay K; Gracie G; Ma CS; Macintosh R; Smith SABC; Sasson SC; Sewell WA; Cowley M; Tangye SG; Kelleher AD; Phan TG, 2018, 'Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable Immunodeficiency',
Journal of Clinical Immunology, vol. 38, pp. 159 - 162,
http://dx.doi.org/10.1007/s10875-018-0477-z2018
Moran I; Nguyen A; Khoo WH; Butt D; Bourne K; Young C; Hermes JR; Biro M; Gracie G; Ma CS; Munier CML; Luciani F; Zaunders J; Parker A; Kelleher AD; Tangye SG; Croucher PI; Brink R; Read MN; Phan TG, 2018, 'Memory B cells are reactivated in subcapsular proliferative foci of lymph nodes',
Nature Communications, vol. 9,
http://dx.doi.org/10.1038/s41467-018-05772-72018
Tsukamoto T; Kariya R; Marks K; Hattori S; Ahlenstiel C; Symonds G; Okada S; Kelleher AD, 2018, 'Erratum: Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34R cells in HIV-1 infection (AIDS (2018) (2018) 32 (1737–1747) DOI: 10.1097/QAD.0000000000001882)',
AIDS, vol. 32, pp. 2857 - 2858,
http://dx.doi.org/10.1097/01.aids.0000547984.16868.932018
Hey-Nguyen WJ; Xu Y; Pearson CF; Bailey M; Suzuki K; Tantau R; Obeid S; Milner B; Field A; Carr A; Bloch M; Cooper DA; Kelleher AD; Zaunders JJ; Koelsch KK, 2017, 'Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes during Antiretroviral Therapy',
AIDS Research and Human Retroviruses, vol. 33, pp. 648 - 657,
http://dx.doi.org/10.1089/aid.2016.01712017
Pinto A; Carrera A; Salem H; Thapa K; Shaik A; Petoumenos K; Cunningham P; Garsia R; Dwyer D; Cooper DA; Kelleher AD, 2017, 'Evolution of HIV-1 surveillance drug resistance mutations over ten years in New South Wales, Australia.',
AIDS Res Hum Retroviruses,
http://dx.doi.org/10.1089/AID.2016.03012017
Xu Y; Phetsouphanh C; Suzuki K; Aggrawal A; Graff-Dubois S; Roche M; Bailey M; Alcantara S; Cashin K; Sivasubramaniam R; Koelsch KK; Autran B; Harvey R; Gorry PR; Moris A; Cooper DA; Turville S; Kent SJ; Kelleher AD; Zaunders J, 2017, 'HIV-1 and SIV predominantly use CCR5 expressed on a precursor population to establish infection in T follicular helper cells',
Frontiers in Immunology, vol. 8,
http://dx.doi.org/10.3389/fimmu.2017.003762017
Juno JA; Bockel DV; Kent SJ; Kelleher AD; Zaunders JJ; Munier CML, 2017, 'Cytotoxic CD4 T cells-friend or foe during viral infection?',
Frontiers in Immunology, vol. 8,
http://dx.doi.org/10.3389/fimmu.2017.000192017
Koelsch KK; Rasmussen TA; Hey-Nguyen WJ; Pearson C; Xu Y; Bailey M; Marks KH; Sasson SC; Taylor MS; Tantau R; Obeid S; Milner B; Morrissey O; Pinto AN; Suzuki K; Busch MP; Keating SM; Kaiser P; Yukl S; Wong JK; Hiener BM; Palmer S; Zaunders J; Post JJ; Chan DJ; Avery S; Milliken ST; Kelleher AD; Lewin SR; Cooper DA, 2017, 'Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals',
Journal of Acquired Immune Deficiency Syndromes, vol. 75, pp. 328 - 337,
http://dx.doi.org/10.1097/QAI.00000000000013812017
McLaren PJ; Pulit SL; Gurdasani D; Bartha I; Shea PR; Pomilla C; Gupta N; Gkrania-Klotsas E; Young EH; Bannert N; Del Amo J; Gill MJ; Gilmour J; Kellam P; Kelleher AD; Sönnerborg A; Zangerle R; Post FA; Fisher M; Haas DW; Walker BD; Porter K; Goldstein DB; Sandhu MS; De Bakker PIW; Fellay J, 2017, 'Evaluating the impact of functional genetic variation on HIV-1 Control',
Journal of Infectious Diseases, vol. 216, pp. 1063 - 1069,
http://dx.doi.org/10.1093/infdis/jix4702017
Castley A; Sawleshwarkar S; Varma R; Herring B; Thapa K; Dwyer D; Chibo D; Nguyen N; Hawke K; Ratcliff R; Garsia R; Kelleher A; Nolan D, 2017, 'A national study of the molecular epidemiology of HIV-1 in',
PLoS ONE, vol. 12,
http://dx.doi.org/10.1371/journal.pone.01706012017
Madhavi V; Kulkarni A; Shete A; Lee WS; McLean MR; Kristensen AB; Ghate M; Wines BD; Hogarth PM; Parsons MS; Kelleher A; Cooper DA; Amin J; Emery S; Thakar M; Kent SJ, 2017, 'Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts',
Journal of Acquired Immune Deficiency Syndromes, vol. 75, pp. 345 - 353,
http://dx.doi.org/10.1097/QAI.00000000000013802017
Phetsouphanh C; Xu Y; Munier ML; Zaunders JJ; Kelleher AD, 2017, 'Single-cell profiling of lineage determining transcription factors in antigen-specific CD4
+ T cells reveals unexpected complexity in recall responses during immune reconstitution',
Immunology and Cell Biology, vol. 95, pp. 640 - 646,
http://dx.doi.org/10.1038/icb.2017.282017
Murray DD; Suzuki K; Law M; Trebicka J; Neuhaus Nordwall J; Johnson M; Vjecha MJ; Kelleher AD; Emery S, 2017, 'Circulating MIR-122 and MIR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals',
Scientific Reports, vol. 7,
http://dx.doi.org/10.1038/s41598-017-11405-82017
Madhavi V; Wines BD; Amin J; Emery S; Lopez E; Kelleher A; Center RJ; Mark Hogarth P; Chung AW; Kent SJ; Stratov I, 2017, 'HIV-1 Env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV',
Journal of Virology, vol. 91,
http://dx.doi.org/10.1128/JVI.00700-172017
Smoleń-Dzirba J; Rosińska M; Janiec J; Beniowski M; Cycoń M; Bratosiewicz-Wąsik J; Wasik TJ; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Lutsar I; Chêne G; Dabis F; Thiebaut R; Masquelier B; Costagliola D; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Meyer L; Boufassa F; Hamouda O; Kücherer C; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Touloumi G; Pantazis N; Katsarou O; Rezza G; Dorrucci M; Monforte AD; De Luca A; Prins M; Geskus R; van der Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AMB; Rosinska M; Muga R; Tor J; de Olalla PG; Cayla J; del Amo J; Moreno S; Monge S; del Romero J; Pérez-Hoyos S; Bucher HC; Rickenbach M; Francioli P; Malyuta R; Murphy G; Sabin C; Porter K; Johnson A; Phillips A; Babiker A; Pillay D; Morrison C; Salata R; Mugerwa R; Chipato T; Amornkul PN; Gilmour J; Kamali A; Karita E; Burns F; Giaquinto C; Gibb D; Grarup J; Kirk O; Kjaer J; Panteleev A; Reiss P; Thorne C; Aboulker JP; Albert J; Asandi S; De Wit S; De Wolf F; Gatell J; Karpov I; Ledergerber B; Lundgren J; Møller C; Rakhmanova A; Rockstroh J; Anne AV, 2017, 'HIV-1 infection in persons homozygous for CCR5-Δ32 allele: The next case and the review', AIDS Reviews, vol. 19, pp. 219 - 230
2017
Nasr N; Alshehri AA; Wright TK; Shahid M; Heiner BM; Harman AN; Botting RA; Helbig KJ; Beard MR; Suzuki K; Kelleher AD; Hertzog P; Cunningham AL, 2017, 'Mechanism of interferon-stimulated gene induction in HIV-1- infected macrophages',
Journal of Virology, vol. 91,
http://dx.doi.org/10.1128/JVI.00744-172017
Cook L; Munier CML; Seddiki N; van Bockel D; Ontiveros N; Hardy MY; Gillies JK; Levings MK; Reid HH; Petersen J; Rossjohn J; Anderson RP; Zaunders JJ; Tye-Din JA; Kelleher AD, 2017, 'Circulating gluten-specific FOXP3
+CD39
+ regulatory T cells have impaired suppressive function in patients with celiac disease',
Journal of Allergy and Clinical Immunology, vol. 140, pp. 1592 - 1603.e8,
http://dx.doi.org/10.1016/j.jaci.2017.02.0152017
Zaunders J; Xu Y; Kent SJ; Koelsch KK; Kelleher AD, 2017, 'Divergent expression of CXCR5 and CCR5 on CD4
+ T cells and the paradoxical accumulation of T follicular helper cells during HIV infection',
Frontiers in Immunology, vol. 8,
http://dx.doi.org/10.3389/fimmu.2017.004952017
Kent SJ; Kelleher AD, 2017, 'Expanding role for type i Interferons in restricting HIV growth',
Immunology and Cell Biology, vol. 95, pp. 417 - 418,
http://dx.doi.org/10.1038/icb.2017.152017
Klemm V; Mitchell J; Cortez-Jugo C; Cavalieri F; Symonds G; Caruso F; Kelleher AD; Ahlenstiel C, 2016, 'Achieving HIV-1 control through RNA-directed gene regulation',
Genes, vol. 7,
http://dx.doi.org/10.3390/genes71201192016
Tjiam MC; Sariputra L; Armitage JD; Taylor JPA; Kelleher AD; Tan DBA; Lee S; Fernandez S; French MA, 2016, 'Control of early HIV-1 infection associates with plasmacytoid dendritic cell-reactive opsonophagocytic IgG antibodies to HIV-1 p24',
AIDS, vol. 30, pp. 2757 - 2765,
http://dx.doi.org/10.1097/QAD.00000000000012422016
Keoshkerian E; Hunter M; Cameron B; Nguyen N; Sugden P; Bull R; Zekry A; Maher L; Seddiki N; Zaunders J; Kelleher A; Lloyd AR; Dolan K; Haber P; Rawlinson W; Treloar C; Dore G; Luciani F, 2016, 'Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection',
Journal of Viral Hepatitis, vol. 23, pp. 985 - 993,
http://dx.doi.org/10.1111/jvh.125762016
Li J; Hardy K; Phetsouphanh C; Tu WJ; Sutcliffe EL; McCuaig R; Sutton CR; Zafar A; Mee Ling Munier C; Zaunders JJ; Xu Y; Theodoratos A; Tan A; SiewLim P; Knaute T; Masch A; Zerweck J; Brezar V; Milburn PJ; Dunn J; Casarotto MG; Turner SJ; Seddiki N; Kelleher AD; Rao S, 2016, 'Nuclear PKC-θ facilitates rapid transcriptional responses in human memory CD4
+T cells through p65 and H2B phosphorylation',
Journal of Cell Science, vol. 129, pp. 2448 - 2461,
http://dx.doi.org/10.1242/jcs.1812482016
Pinkevych M; Kent SJ; Tolstrup M; Lewin SR; Cooper DA; Søgaard OS; Rasmussen TA; Kelleher AD; Cromer D; Davenport MP, 2016, 'Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5–8 Days',
PLoS Pathogens, vol. 12,
http://dx.doi.org/10.1371/journal.ppat.10057402016
Pantazis N; Touloumi G; Meyer L; Olson A; Costagliola D; Kelleher AD; Lutsar I; Chaix ML; Fisher M; Moreno S; Porter K, 2016, 'The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment',
AIDS, vol. 30, pp. 879 - 888,
http://dx.doi.org/10.1097/QAD.00000000000009912016
Pinkevych M; Cromer D; Tolstrup M; Grimm AJ; Cooper DA; Lewin SR; Søgaard OS; Rasmussen TA; Kent SJ; Kelleher AD; Davenport MP, 2016, 'Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission.',
PLoS Pathog, vol. 12, pp. e1005745,
http://dx.doi.org/10.1371/journal.ppat.10057452016
McAllery SA; Ahlenstiel CL; Suzuki K; Symonds GP; Kelleher AD; Turville SG, 2016, 'The feasibility of incorporating Vpx into lentiviral gene therapy vectors',
Molecular Therapy - Methods and Clinical Development, vol. 3, pp. 16066,
http://dx.doi.org/10.1038/mtm.2016.662016
Munier CML; van Bockel D; Bailey M; Ip S; Xu Y; Alcantara S; Liu SM; Denyer G; Kaplan W; Suzuki K; Croft N; Purcell A; Tscharke D; Cooper DA; Kent SJ; Zaunders JJ; Kelleher AD, 2016, 'The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype',
Vaccine, vol. 34, pp. 5251 - 5261,
http://dx.doi.org/10.1016/j.vaccine.2016.09.0092016
Zaunders J; Jing J; Leipold M; Maecker H; Kelleher AD; Koch I, 2016, 'Computationally efficient multidimensional analysis of complex flow cytometry data using second order polynomial histograms',
Cytometry Part A, vol. 89, pp. 44 - 58,
http://dx.doi.org/10.1002/cyto.a.227042016
Cook L; Zaunders JJ; Kelleher AD, 2016, 'Comment on "A cytokine- independent approach to identify antigen-specific human germinal center T follicular helper cells and rare antigen-specific CD41 T cells in blood',
Journal of Immunology, vol. 197, pp. 2557 - 2558,
http://dx.doi.org/10.4049/jimmunol.16013112016
Pett SL; Amin J; Horban A; Andrade-Villanueva J; Losso M; Porteiro N; Madero JS; Belloso W; Tu E; Silk D; Kelleher A; Harrigan R; Clark A; Sugiura W; Wolff M; Gill J; Gatell J; Fisher M; Clarke A; Ruxrungtham K; Prazuck T; Kaiser R; Woolley I; Arnaiz JA; Cooper D; Rockstroh JK; Mallon P; Emery S, 2016, 'Maraviroc, as a switch option, in HIV-1-infected individuals with stable, well-controlled HIV replication and R5-tropic virus on their first Nucleoside/Nucleotide reverse transcriptase inhibitor plus ritonavir-boosted protease inhibitor regimen: Week 48 Results of the randomized, multicenter March study',
Clinical Infectious Diseases, vol. 63, pp. 122 - 132,
http://dx.doi.org/10.1093/cid/ciw2072016
Zaunders J; Danta M; Bailey M; Mak G; Marks K; Seddiki N; Xu Y; Templeton DJ; Cooper DA; Boyd MA; Kelleher AD; Koelsch KK, 2016, 'CD4
+ T follicular helper and IgA
+ B cell numbers in gut biopsies from HIV-infected subjects on antiretroviral therapy are similar to HIV-uninfected individuals',
Frontiers in Immunology, vol. 7,
http://dx.doi.org/10.3389/fimmu.2016.004382016
Hurst J; Hoffmann M; Pace M; Williams JP; Thornhill J; Hamlyn E; Meyerowitz J; Willberg C; Koelsch KK; Robinson N; Brown H; Fisher M; Kinloch S; Cooper DA; Schechter M; Tambussi G; Fidler S; Babiker A; Weber J; Kelleher AD; Phillips RE; Frater J, 2015, 'Immunological biomarkers predict HIV-1 viral rebound after treatment interruption',
Nature Communications, vol. 6,
http://dx.doi.org/10.1038/ncomms94952015
Tong WWY; Shepherd K; Garland S; Meagher A; Templeton DJ; Fairley CK; Jin F; Poynten IM; Zaunders J; Hillman RJ; Grulich AE; Kelleher AD; Carr A; Acraman B; Fraissard E; Law C; McGrath P; Mellor R; Norris R; O'Dwyer M; Seeds D; Thompson K; Varma R; Adams M; Biro C; Cornall A; Crampton L; Ekman D; Ellard J; Farnsworth A; Feeney L; Howard K; Hyne S; Law M; Machalek D; McCaffery K; McDonald R; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Roberts J; Schema L; Segelov E; Tabrizi S; Thurloe J; Bailey M; Cunningham P; Fsadni B; Grassi K; Ip S; Lograsso M; McBride K; Merlin K; Munier M-L; Piperias M; Xu Y, 2015, 'Human Papillomavirus 16-Specific T-Cell Responses and Spontaneous Regression of Anal High-Grade Squamous Intraepithelial Lesions',
Journal of Infectious Diseases, vol. 211, pp. 405 - 415,
http://dx.doi.org/10.1093/infdis/jiu4612015
Pantazis N; Touloumi G; Meyer L; Olson A; Costagliola D; Kelleher AD; Lutsar I; Chaix ML; Fisher M; Moreno S; Porter K, 2015, 'The impact of transient cART in early HIV infection on viral suppression and immunologic response in later treatment',
AIDS,
http://dx.doi.org/10.1097/QAD.00000000000009912015
Phetsouphanh C; Zaunders JJ; Kelleher AD, 2015, 'Detecting antigen-specific T cell responses: From bulk populations to single cells',
International Journal of Molecular Sciences, vol. 16, pp. 18878 - 18893,
http://dx.doi.org/10.3390/ijms1608188782015
Hoehn KB; Gall A; Bashford-Rogers R; Fidler SJ; Kaye S; Weber JN; McClure MO; Kellam P; Pybus OG; Breckenridge A; Clayden P; Conlon C; Conradie F; Kaldor J; Maggiolo F; Ssali F; Cooper DA; Kaleebu P; Ramjee G; Schechter M; Tambussi G; Weber J; Fidler S; Babiker A; Peto T; McLaren A; Beral V; Chene G; Hakim J; Porter K; Thomason M; Ewings F; Gabriel M; Johnson D; Thompson K; Cursley A; Donegan K; Fossey E; Kelleher P; Lee K; Murphy B; Nock D; Phillips R; Frater J; Ohm Laursen L; Robinson N; Goulder P; Brown H; McClure M; Bonsall D; Erlwein O; Helander A; Robinson M; Cook L; Adcock G; Ahmed P; Paton N; Kelleher A; Moore R; McFarlane R; Roth N; Finlayson R; Tee BK; Read T; Kelly M; Doong N; Bloch M; Workman C; Grey P; Cooper DA; Lawr M; Schechter M; Gama P; Mercon M; Barbosa de Souza M; Beppu Yoshida C; Grangeiro da Silva JR; Sampaio Amaral A; Fernandes de Aguiar D; de Fátima Melo M; Quaresma Garrido R; Tambussi G; Nozza S; Pogliaghi M; Chiappetta S; Della Torre L; Gasparotto E; D'Offizi G; Vlassi C; Corpolongo A; Wood R; Pitt J; Orrell C; Cilliers F; Croxford R, 2015, 'Dynamics of immunoglobulin sequence diversity in HIV-1 infected individuals',
Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 370,
http://dx.doi.org/10.1098/rstb.2014.02412015
Ahlenstiel C; Mendez C; Lim STH; Marks K; Turville S; Cooper DA; Kelleher AD; Suzuki K, 2015, 'Novel RNA duplex locks HIV-1 in a latent state via chromatin-mediated transcriptional silencing',
Molecular Therapy - Nucleic Acids, vol. 4, pp. e261,
http://dx.doi.org/10.1038/mtna.2015.312015
Suzuki K; Ahlenstiel C; Marks K; Kelleher AD, 2015, 'Promoter targeting RNAs: Unexpected contributors to the control of HIV-1 transcription',
Molecular Therapy - Nucleic Acids, vol. 4,
http://dx.doi.org/10.1038/mtna.2014.672015
Ahlenstiel CL; Suzuki K; Marks K; Symonds GP; Kelleher AD, 2015, 'Controlling HIV-1: Non-coding RNA gene therapy approaches to a functional cure',
Frontiers in Immunology, vol. 6,
http://dx.doi.org/10.3389/fimmu.2015.004742015
Madhavi V; Ana-Sosa-Batiz FE; Jegaskanda S; Center RJ; Winnall WR; Parsons MS; Ananworanich J; Cooper DA; Kelleher AD; Hsu D; Pett S; Stratov I; Kramski M; Kent SJ, 2015, 'Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy',
Journal of Infectious Diseases, vol. 211, pp. 529 - 538,
http://dx.doi.org/10.1093/infdis/jiu4862015
Zaunders J; Jing J; Leipold M; Maecker H; Kelleher AD; Koch I, 2015, 'Computationally efficient multidimensional analysis of complex flow cytometry data using second order polynomial histograms',
Cytometry Part A,
http://dx.doi.org/10.1002/cyto.a.227042015
Suan D; Nguyen A; Moran I; Bourne K; Hermes JR; Arshi M; Hampton HR; Tomura M; Miwa Y; Kelleher AD; Kaplan W; Deenick EK; Tangye SG; Brink R; Chtanova T; Phan TG, 2015, 'T Follicular Helper Cells Have Distinct Modes of Migration and Molecular Signatures in Naive and Memory Immune Responses',
Immunity, vol. 42, pp. 704 - 718,
http://dx.doi.org/10.1016/j.immuni.2015.03.0022015
Amin J; Becker S; Belloso W; Boffito M; Cooper D; Crabtree-Ramirez B; Duncombe C; Foulkes S; Hill A; Jessen H; Kumar S; Lee MP; Nwizu C; Read T; Rooney J; Schaffer K; Shahar E; Winston A; Wolff M; Young B; Abela C; Avihingsanon A; Boyd M; Carey D; Clarke A; Courtney-Vega K; Delfino M; Donaldson A; Emery S; Espinosa N; Johannesen T; Lin E; Losso M; Moricz A; Pett S; Phanupak P; Puls R; Pussadee K; Sutheerasak P; Tomlins L; Ubolyam S; bin Raja Azwa RIS; Bissio E; Calanni L; Chetchotisakd P; Doong N; Elliott J; Gazzard B; Kelly M; Laplume H; del Carmen Luna N; Lupo S; Messina OG; Mohapi L; Moore R; Nolan D; Orrell C; Perez C; Phanuphak P; Rockstroh J; Rowling D; Supparatpinyo K; Smith D; Villanueva JA; Vlahakis E; Kelleher T; Cunningham P; Merlin K; Yeung J; Shaik A; Fsadni B; Carrera A; Lograsso M; Gulick R; Dunn D; Dolan M, 2015, 'Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study',
The Lancet Infectious Diseases, vol. 15, pp. 793 - 802,
http://dx.doi.org/10.1016/S1473-3099(15)70060-52015
Hey-Cunningham WJ; Murray JM; Natarajan V; Amin J; Moore CL; Emery S; Cooper DA; Zaunders J; Kelleher AD; Koelsch KK; PINT study team , 2015, 'Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.',
AIDS, vol. 29, pp. 911 - 919,
http://dx.doi.org/10.1097/QAD.00000000000006252015
Méndez C; Ahlenstiel CL; Kelleher AD, 2015, 'Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.',
World J Virol, vol. 4, pp. 219 - 244,
http://dx.doi.org/10.5501/wjv.v4.i3.2192015
Colineau L; Rouers A; Yamamoto T; Xu Y; Urrutia A; Pham HP; Cardinaud S; Samri A; Dorgham K; Coulon PG; Cheynier R; Hosmalin A; Oksenhendler E; Six A; Kelleher AD; Zaunders J; Koup RA; Autran B; Moris A; Graff-Dubois S, 2015, 'HIV-infected spleens present altered follicular helper T cell (Tfh) subsets and skewed B cell maturation',
PLoS ONE, vol. 10,
http://dx.doi.org/10.1371/journal.pone.01409782015
Winston A; Amin J; Clarke A; Else L; Amara A; Owen A; Barber T; Jessen H; Avinghsanon A; Chetchotisakd P; Khoo S; Cooper DA; Emery S; Puls R, 2015, 'Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: A randomized controlled trial',
Clinical Infectious Diseases, vol. 60, pp. 1026 - 1032,
http://dx.doi.org/10.1093/cid/ciu9762015
Jarrin I; Pantazis N; Dalmau J; Phillips AN; Olson A; Mussini C; Boufassa F; Costagliola D; Porter K; Blanco J; Del Amo J; Martinez-Picado J; Chene G; Sabin C; Walker S; Fisher M; Kelleher T; Cooper D; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Lutsar I; Dabis F; Thiebaut R; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Meyer L; Hamouda O; Kucherer C; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Touloumi G; Katsarou O; Rezza G; Dorrucci M; Monforte ADA; De Luca A; Prins M; Geskus R; Van Der Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AMB; Rosinska M; Muga R; Tor J; De Olalla PG; Cayla J; Moreno S; Monge S; Del Romero J; Perez-Hoyos S; Sonnerborg A; Bucher HC; Gunthard H; Rickenbach M; Malyuta R; Murphy G; Johnson A; Babiker A; Pillay D; Morrison C; Salata R; Mugerwa R; Chipato T; Amornkul PN; Gilmour J; Kamali A; Karita E; Burns F; Giaquinto C; Grarup J; Kirk O; Bailey H; Anne AV; Panteleev A; Thorne C; Aboulker JP; Albert J; Asandi S; De Wit S; Reiss P; Gatell J; Karpov I; Ledergerber B; Lundgren J; Møller C; Rakhmanova A; Rockstroh J; Sandhu M; Dedes N, 2015, 'Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4 + T-cell recovery once HIV-1 suppression is achieved?',
AIDS, vol. 29, pp. 2323 - 2333,
http://dx.doi.org/10.1097/QAD.00000000000008052015
Fernandez CS; Amarasena T; Kelleher AD; Rossjohn J; Mccluskey J; Godfrey DI; Kent SJ, 2015, 'MAIT cells are depleted early but retain functional cytokine expression in HIV infection',
Immunology and Cell Biology, vol. 93, pp. 177 - 188,
http://dx.doi.org/10.1038/icb.2014.912015
Pinkevych M; Cromer D; Tolstrup M; Grimm AJ; Cooper DA; Lewin SR; Søgaard OS; Rasmussen TA; Kent SJ; Kelleher AD; Davenport MP, 2015, 'HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission',
PLoS Pathogens, vol. 11,
http://dx.doi.org/10.1371/journal.ppat.10050002015
Lundgren JD; Babiker AG; Gordin F; Emery S; Grund B; Sharma S; Avihingsanon A; Cooper DA; Fätkenheuer G; Llibre JM; Molina JM; Munderi P; Schechter M; Wood R; Klingman KL; Collins S; Clifford Lane H; Phillips AN; Neaton JD, 2015, 'Initiation of antiretroviral therapy in early asymptomatic HIV infection',
New England Journal of Medicine, vol. 373, pp. 795 - 807,
http://dx.doi.org/10.1056/NEJMoa15068162015
Murray DD; Suzuki K; Law M; Trebicka J; Neuhaus J; Wentworth D; Johnson M; Vjecha MJ; Kelleher AD; Emery S; Aagaard B; Aragon E; Arnaiz J; Borup L; Clotet B; Dragsted U; Fau A; Gey D; Grarup J; Hengge U; Herrero P; Jansson P; Jensen B; Jensen K; Juncher H; Lopez P; Lundgren JD; Matthews C; Mollerup D; Pearson M; Phillips A; Reilev S; Tillmann K; Varea S; Angus B; Babiker A; Cordwell B; Darbyshire J; Dodds W; Fleck S; Horton J; Hudson F; Moraes Y; Pacciarini F; Palfreeman A; Paton N; Smith N; Van Hooff F; Bebchuk J; Collins G; Denning E; DuChene A; Fosdick L; Harrison M; Herman-Lamin K; Krum E; Larson G; Neaton J; Nelson R; Quan K; Quan S; Schultz T; Thompson G; Wyman N; Carey C; Chan F; Cooper D; Courtney-Rodgers D; Drummond F; Harrod M; Jacoby S; Kearney L; Lin E; Pett S; Robson R; Seneviratne N; Stewart M; Watts E; Finley E; Gordin F; Sánchez A; Standridge B; Belloso W; Davey R; Duprez D; Gatell J; Hoy J; Lifson A; Pederson C; Perez G; Price R; Prineas R; Rhame F; Sampson J; Worley J; Modlin J; Beral V; Chaisson R; Fleming T; Hill C, 2015, 'Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study',
PLoS ONE, vol. 10,
http://dx.doi.org/10.1371/journal.pone.01399812015
Boyd MA; Moore CL; Molina JM; Wood R; Madero JS; Wolff M; Ruxrungtham K; Losso M; Renjifo B; Teppler H; Kelleher AD; Amin J; Emery S; Cooper DA, 2015, 'Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: An exploratory analysis',
The Lancet HIV, vol. 2, pp. e42 - e51,
http://dx.doi.org/10.1016/S2352-3018(14)00061-72015
Sasson SC; McGill K; Wienholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA, 2015, 'Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay',
Pathology, vol. 47, pp. 564 - 569,
http://dx.doi.org/10.1097/PAT.00000000000003162015
Pantazis N; Porter K; Costagliola D; De Luca A; Ghosn J; Guiguet M; Johnson AM; Kelleher AD; Morrison C; Thiebaut R; Wittkop L; Touloumi G, 2014, 'Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: An observational cohort study',
The Lancet HIV, vol. 1, pp. e119 - e126,
http://dx.doi.org/10.1016/S2352-3018(14)00002-22014
Haskelberg H; Cordery DV; Amin J; Kelleher AD; Cooper DA; Emery S, 2014, 'HLA Alleles association with changes in bone mineral density in HIV-1-infected adults changing treatment to tenofovir-emtricitabine or abacavir-lamivudine',
PLoS ONE, vol. 9,
http://dx.doi.org/10.1371/journal.pone.00933332014
Amin J; Becker S; Belloso W; Boffito M; Cooper D; Crabtree-Ramirez B; Duncombe C; Emery S; Foulkes S; Hill A; Jessen H; Kumar S; Lee MP; Losso M; Nwizu C; Phanuphak P; Ripin D; Read T; Rooney J; Schaffer K; Shahar E; Winston A; Wolff M; Young B; Abela C; Boyd M; Carey D; Clarke A; Courtney-Vega K; Dazo C; Delfino M; Donaldson A; Espinosa N; Johannesen T; Kaew-On P; Lin E; Moricz A; Taylor J; Phanupak P; Puls RL; Pussadee K; Sutheerasak P; Tomkins L; Ubolyam S; Shah Bin Raja Azwa RI; Bissio E; Calanni L; Casiro A; Chetchotisakd P; Contarelli J; Doong N; Elliott J; Gazzard B; Kelly M; Del Carmen Luna N; Lupo S; Messina OG; Mohapi L; Moore R; Nolan D; Orrell C; Perez C; Pett S; Rockstroh J; Supparatpinyo K; Smith D; Villanueva JA; Vlahakis E; Kelleher T; Cunningham P; Merlin K; Yeung J; Shaik A; Fsadni B; Carrera A; Lograsso M; Gulick R; Crabtree-Ramiraz B; Winston E; Dunn D; Dolan M, 2014, 'Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): A randomised, double-blind, placebo-controlled, non-inferiority trial',
The Lancet, vol. 383, pp. 1474 - 1482,
http://dx.doi.org/10.1016/S0140-6736(13)62187-X2014
Bavinton BR; Jin F; Prestage G; Zablotska I; Koelsch KK; Phanuphak N; Grinsztejn B; Cooper DA; Fairley C; Kelleher A; Triffitt K; Grulich AE, 2014, 'The Opposites Attract Study of viral load, HIV treatment and HIV transmission in serodiscordant homosexual male couples: Design and methods',
BMC Public Health, vol. 14,
http://dx.doi.org/10.1186/1471-2458-14-9172014
Martin E; Carlson JM; Le AQ; Chopera DR; McGovern R; Rahman MA; Ng C; Jessen H; Kelleher AD; Markowitz M; Allen TM; Milloy MJ; Carrington M; Wainberg MA; Brumme ZL, 2014, 'Early immune adaptation in HIV-1 revealed by population-level approaches',
Retrovirology, vol. 11,
http://dx.doi.org/10.1186/s12977-014-0064-12014
Williams JP; Hurst J; Stöhr W; Robinson N; Brown H; Fisher M; Kinloch S; Cooper D; Schechter M; Tambussi G; Fidler S; Carrington M; Babiker A; Weber J; Koelsch KK; Kelleher AD; Phillips RE; Frater J, 2014, 'HIV-1 DNA predicts disease progression and post-treatment virological control',
eLife, vol. 3, pp. e03821,
http://dx.doi.org/10.7554/eLife.038212014
Pham QD; Wilson DP; Law MG; Kelleher AD; Zhang L, 2014, 'Global burden of transmitted HIV drug resistance and HIV-exposure categories: A systematic review and meta-analysis',
AIDS, vol. 28, pp. 2751 - 2762,
http://dx.doi.org/10.1097/QAD.00000000000004942014
Ana-Sosa-Batiz F; Johnston APR; Liu H; Center RJ; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Kaewkungwal J; Kim JH; Michael NL; Kelleher AD; Stratov I; Kent SJ; Kramski M, 2014, 'HIV-specific antibody-dependent phagocytosis matures during HIV infection',
Immunology and Cell Biology, vol. 92, pp. 679 - 687,
http://dx.doi.org/10.1038/icb.2014.422014
Phetsouphanh C; Xu Y; Bailey M; Pett S; Zaunders J; Seddiki N; Kelleher AD, 2014, 'Ratios of effector to central memory antigen-specific CD4 + T cells vary with antigen exposure in HIV+ patients',
Immunology and Cell Biology, vol. 92, pp. 384 - 388,
http://dx.doi.org/10.1038/icb.2013.1012014
Seddiki N; Cook L; Hsu DC; Phetsouphanh C; Brown K; Xu Y; Kerr SJ; Cooper DA; Munier CML; Pett S; Ananworanich J; Zaunders J; Kelleher AD, 2014, 'Human antigen-specific CD4
+CD25
+CD134
+CD39
+ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses',
European Journal of Immunology, vol. 44, pp. 1644 - 1661,
http://dx.doi.org/10.1002/eji.2013441022014
Tong WWY; Hillman RJ; Kelleher AD; Grulich AE; Carr A, 2014, 'Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults',
HIV Medicine, vol. 15, pp. 65 - 76,
http://dx.doi.org/10.1111/hiv.120802014
Streeck H; Lu R; Beckwith N; Milazzo M; Liu M; Routy JP; Little S; Jessen H; Kelleher AD; Hecht F; Sekaly RP; Alter G; Heckerman D; Carrington M; Rosenberg ES; Altfeldc M, 2014, 'Emergence of individual HIV-specific CD8 T cell responses during primary HIV-1 infection can determine long-term disease outcome',
Journal of Virology, vol. 88, pp. 12793 - 12801,
http://dx.doi.org/10.1128/JVI.02016-142014
Achhra AC; Boyd MA; Law MG; Matthews GV; Kelleher AD; Cooper DA, 2014, 'Moving away from ritonavir, abacavir, tenofovir, and efavirenz (RATE) - Agents that concern prescribers and patients: A feasibility study and call for a trial',
PLoS ONE, vol. 9,
http://dx.doi.org/10.1371/journal.pone.00995302014
Sasson SC; Kelleher AD, 2014, 'Site-specific host gene modification by zinc finger nucleases: pointing the way to drug free control of HIV-1?',
CLINICAL & TRANSLATIONAL IMMUNOLOGY, vol. 3,
http://dx.doi.org/10.1038/cti.2014.122014
Hsu DC; Kerr SJ; Thongpaeng P; Iampornsin T; Pett SL; Zaunders JJ; Avihingsanon A; Ubolyam S; Ananworanich J; Kelleher AD; Cooper DA, 2014, 'Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy',
Journal of Infection, vol. 68, pp. 344 - 354,
http://dx.doi.org/10.1016/j.jinf.2013.11.0162014
Amin J; Law MG; Puls R; Kelleher A; Cooper DA; Emery S, 2014, 'Comparison of central and local HIV-1 RNA quantification from two international clinical trials',
AIDS, vol. 28, pp. 2480 - 2483,
http://dx.doi.org/10.1097/QAD.00000000000004612014
Kuang XT; Li X; Anmole G; Mwimanzi P; Shahid A; Le AQ; Chong L; Qian H; Miura T; Markle T; Baraki B; Connick E; Daar ES; Jessen H; Kelleher AD; Little S; Markowitz M; Pereyra F; Rosenberg ES; Walker BD; Ueno T; Brumme ZL; Brockman MA, 2014, 'Impaired Nef function is associated with early control of HIV-1 viremia',
Journal of Virology, vol. 88, pp. 10200 - 10213,
http://dx.doi.org/10.1128/JVI.01334-142014
Murray JM; Zaunders JJ; McBride KL; Xu Y; Bailey M; Suzuki K; Cooper DA; Emery S; Kelleher AD; Koelsch KK, 2014, 'HIV DNA subspecies persist in both activated and resting memory CD4
+ T cells during antiretroviral therapy',
Journal of Virology, vol. 88, pp. 3516 - 3526,
http://dx.doi.org/10.1128/JVI.03331-132014
Fernandez CS; Kelleher AD; Finlayson R; Godfrey DI; Kent SJ, 2014, 'NKT cell depletion in humans during early HIV infection',
Immunology and Cell Biology, vol. 92, pp. 578 - 590,
http://dx.doi.org/10.1038/icb.2014.252014
Kelleher AD, 2014, 'Promoter targeted small RNAs: stabilising viral reservoirs', Microbiology Australia, vol. 10, pp. 1071
2014
Vaidya SA; Streeck H; Beckwith N; Ghebremichael M; Pereyra F; Kwon DS; Addo MM; Rychert J; Routy JP; Jessen H; Kelleher AD; Hecht F; Sekaly RP; Carrington M; Walker BD; Allen TM; Rosenberg ES; Altfeld M, 2013, 'Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection',
Retrovirology, vol. 10,
http://dx.doi.org/10.1186/1742-4690-10-1392013
McBride K; Xu Y; Bailey M; Seddiki N; Suzuki K; Murray JM; Gao Y; Yan C; Cooper DA; Kelleher AD; Koelsch KK; Zaunders J, 2013, 'The majority of HIV type 1 DNA in circulating CD4
+ T lymphocytes is present in non-gut-homing resting memory CD4
+ T cells',
AIDS Research and Human Retroviruses, vol. 29, pp. 1330 - 1339,
http://dx.doi.org/10.1089/aid.2012.03512013
Gilmore JB; Kelleher AD; Cooper DA; Murray JM, 2013, 'Explaining the determinants of first phase HIV decay dynamics through the effects of stage-dependent drug action',
PLoS Computational Biology, vol. 9, pp. e1002971 (11pp),
http://dx.doi.org/10.1371/journal.pcbi.10029712013
Phetsouphanh C; Xu Y; Amin J; Seddiki N; Procopio F; Sekaly RP; Zaunders JJ; Kelleher AD, 2013, 'Characterization of Transcription Factor Phenotypes within Antigen-Specific CD4+ T Cells Using Qualitative Multiplex Single-Cell RT-PCR',
PLoS ONE, vol. 8,
http://dx.doi.org/10.1371/journal.pone.00749462013
Kent SJ; Reece JC; Petravic J; Martyushev A; Kramski M; De Rose R; Cooper DA; Kelleher AD; Emery S; Cameron PU; Lewin SR; Davenport MP, 2013, 'The search for an HIV cure: Tackling latent infection',
The Lancet Infectious Diseases, vol. 13, pp. 614 - 621,
http://dx.doi.org/10.1016/S1473-3099(13)70043-42013
French MA; Center RJ; Wilson KM; Fleyfel I; Fernandez S; Schorcht A; Stratov I; Kramski M; Kent SJ; Kelleher AD, 2013, 'Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers',
AIDS, vol. 27, pp. 519 - 528,
http://dx.doi.org/10.1097/QAD.0b013e32835cb7202013
Seddiki N; Phetsouphanh C; Swaminathan S; Xu Y; Rao S; Li J; Sutcliffe E; Denyer G; Finlayson R; Gelgor L; Cooper DA; Zaunders J; Kelleher AD, 2013, 'The microRNA-9/B-lymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive HIV infection',
European Journal of Immunology, vol. 43, pp. 510 - 520,
http://dx.doi.org/10.1002/eji.2012426952013
Xu Y; Weatherall CJ; Bailey MR; Alcantara S; De Rose R; Estaquier J; Wilson KM; Suzuki K; Corbeil J; Cooper DA; Kent SJ; Kelleher AD; Zaunders J, 2013, 'Simian immunodeficiency virus infects follicular helper CD4 T cells in lymphoid tissues during pathogenic infection of pigtail macaques',
Journal of Virology, vol. 87, pp. 3760 - 3773,
http://dx.doi.org/10.1128/JVI.02497-122013
Porter K; Ewings FM; Ramjee G; Cooper DA; Fisher M; Schechter MT; Tambussi G; Kinloch-De Loes S; Miro J; Kelleher AD; Mcclure MO; Gabriel M; Phillips R; Weber J; Babiker AG, 2013, 'Short-course antiretroviral therapy in primary HIV infection',
New England Journal of Medicine, vol. 368, pp. 207 - 217,
http://dx.doi.org/10.1056/NEJMoa11100392013
Murray JM; Zaunders JJ; Koelsch KK; Natarajan V; Badralmaa Y; McBride K; Carrera A; Cooper DA; Emery S; Kelleher AD, 2013, 'Short communication: HIV blips while on antiretroviral therapy can indicate consistently detectable viral levels due to assay underreporting',
AIDS Research and Human Retroviruses, vol. 29, pp. 1621 - 1625,
http://dx.doi.org/10.1089/aid.2013.01322013
Hsu DC; Kerr SJ; Iampornsin T; Pett SL; Avihingsanon A; Thongpaeng P; Zaunders JJ; Ubolyam S; Ananworanich J; Kelleher AD; Cooper DA, 2013, 'Restoration of CMV-Specific-CD4 T Cells with ART Occurs Early and Is Greater in Those with More Advanced Immunodeficiency',
PLoS ONE, vol. 8,
http://dx.doi.org/10.1371/journal.pone.00774792013
Tu E; Swenson LC; Land S; Pett S; Emery S; Marks K; Kelleher AD; Kaye S; Kaiser R; Schuelter E; Harrigan R, 2013, 'Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc switch collaborative study',
Journal of Clinical Microbiology, vol. 51, pp. 2063 - 2071,
http://dx.doi.org/10.1128/JCM.00510-132013
Suzuki K; Hattori S; Marks K; Ahlenstiel C; Maeda Y; Ishida T; Millington M; Boyd M; Symonds G; Cooper DA; Okada S; Kelleher AD, 2013, 'Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing',
Molecular Therapy - Nucleic Acids, vol. 2, pp. e137,
http://dx.doi.org/10.1038/mtna.2013.642013
Wren LH; Chung AW; Isitman G; Kelleher AD; Parsons MS; Amin J; Cooper DA; Stratov SI; Navis M; Kent SJ, 2012, 'Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection',
Immunology, vol. 138, pp. 116 - 123,
http://dx.doi.org/10.1111/imm.120162012
Brockman M; Chopera DR; Olvera A; Brumme C; Sela J; Markle TJ; Martin EPG; Carlson JM; Le AQ; Mcgovern R; Cheung PK; Kelleher AD; Jessen H; Markowitz M; Rosenberg E; Frahm N; Sanchez J; Mallal S; John M; Harrigan PR; Heckerman D; Brander C; Walker BD; Brummea ZL, 2012, 'Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity',
Journal of Virology, vol. 86, pp. 6913 - 6923,
http://dx.doi.org/10.1128/JVI.07133-112012
Hsu DC; Zaunders J; Plit ML; Leeman C; Ip S; Iampornsin T; Pett SL; Bailey MR; Amin J; Ubolyam S; Avihingsanon A; Ananworanich J; Ruxrungtham K; Cooper DA; Kelleher AD, 2012, 'A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assays',
Tuberculosis, vol. 92, pp. 321 - 327,
http://dx.doi.org/10.1016/j.tube.2012.03.0082012
Kramski M; Schorcht A; Johnston APR; Lichtfuss G; Jegaskanda S; De rose R; Stratov I; Kelleher AD; French MA; Center RJ; Jaworowski A; Kent SJ, 2012, 'Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity',
Journal of Immunological Methods, vol. 384, pp. 51 - 61,
http://dx.doi.org/10.1016/j.jim.2012.07.0062012
Lodi S; Meyer L; Kelleher AD; Rosinska M; Ghosn J; Sannes M; Porter K, 2012, 'Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion',
Annals of Internal Medicine, vol. 172, pp. 1252 - 1255,
http://dx.doi.org/10.1001/archinternmed.2012.27192012
Cordery D; Martin A; Kelleher AD; Emery S; Cooper DA, 2012, 'The influence of HLA supertype on thymidine analogue associated with low peripheral fat in HIV.',
AIDS, vol. 26, pp. 2337 - 2344,
http://dx.doi.org/10.1097/QAD.0b013e32835ab2132012
Sasson SC; Zaunders J; Seddiki N; Mcbride K; Koelsch KK; Merlin KM; Smith DE; Cooper DA; Kelleher AD; Bailey MR, 2012, 'Progressive activation of CD127+132- recent thymic emigrants into terminally differentiated CD127-132+ T-cells in HIV-1 infection',
PLoS One, vol. 7, pp. e31148,
http://dx.doi.org/10.1371/journal.pone.00311482012
Chung AW; Navis M; Isitman G; Centre R; Finlayson RJ; Bloch M; Gelgor L; Kelleher AD; Kent SJ; Stratov I, 2011, 'Activation of NK cells by ADCC responses during early HIV infection',
Viral Immunology, vol. 24, pp. 171 - 175,
http://dx.doi.org/10.1089/vim.2010.01082011
Murray JM; Kelleher ; Cooper DA, 2011, 'Timing of the components of the HIV life cycle in productively infected CD4+ T cells in a population of HIV-infected individuals',
Journal of Virology, vol. 85, pp. 10798 - 10805,
http://dx.doi.org/10.1128/JVI.05095-112011
Van Bockel DJ; Ammaranond P; Petoumenos K; Mcmurchie M; Finlayson RJ; Middleton MG; Davenport ; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD, 2011, 'HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome',
Journal of Immunology, vol. 186, pp. 479 - 488,
http://dx.doi.org/10.4049/jimmunol.09032272011
Sutcliffe E; Bunting KL; He YQ; Li J; Phetsouphanh C; Seddiki N; Zafar A; Hindmarsh EJ; Parish CR; Kelleher AD; Mcinnes RL; Taya T; Milburn PJ; Rao S, 2011, 'Chromatin-Associated Protein Kinase C-è Regulates an Inducible Gene Expression Program and MicroRNAs in Human T Lymphocytes',
Molecular Cell, vol. 41, pp. 704 - 719,
http://dx.doi.org/10.1016/j.molcel.2011.02.0302011
Sauce D; Larsen M; Fastenackels S; Pauchard M; Ait-mohand H; Schneider L; Guihot A; Boufassa F; Zaunders J; Iguertsira M; Bailey M; Gorochov G; Duvivier C; Carcelain G; Kelleher AD; Simon A; Meyer L; Costagliola D; Deeks SG; Lambotte O; Autran B; Hunt P; Katlama C; Appay V, 2011, 'HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis',
Blood, vol. 117, pp. 5142 - 5151,
http://dx.doi.org/10.1182/blood-2011-01-3313062011
Sirivichayakul S; Thantiworasit P; Chatkulkawin P; Buranapraditkun S; Munier ML; Kelleher AD; Ruxrungtham K, 2011, 'Immunogenicity assay validation for an HIV vaccine trial: High IFNã+/IL-2+ CD8+ T cells background in healthy Thais',
Vaccine, vol. 29, pp. 6002 - 6007,
http://dx.doi.org/10.1016/j.vaccine.2011.06.0352011
Iglesias MA; Almeida JR; Fastenackels S; Van Bockel DJ; Hashimoto M; Venturi V; Gostick E; Urrutia A; Wooldridge L; Clement M; Gras S; Wilmann P; Autran B; Moris A; Rossjohn J; Davenport MP; Takiguchi M; Brander C; Douek D; Kelleher AD; Price DA; Appay V, 2011, 'Escape from highly effective public CD8+ T-cell clonotypes by HIV',
Blood, vol. 118, pp. 2138 - 2149,
http://dx.doi.org/10.1182/blood-2011-01-3287812011
Matthews PC; Leslie AJ; Katzourakis A; Crawford H; Payne R; Prendergast A; Power K; Kelleher AD; Klenerman P; Carlson J; Heckerman D; Ndung'u T; Walker BD; Allen TM; Pybus OG; Goulder PJR, 2011, 'HLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering',
Journal of Virology, vol. 85, pp. 4635,
http://dx.doi.org/10.1128/JVI.00375-112011
Byakwaga H; Purcell DJ; French MA; Amin J; Lewin S; Haskelberg H; Kelleher AD; Garsia RJ; Boyd MA; Cooper DA; Emery S, 2011, 'Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4 + T-cell response: A randomized controlled trial',
Journal of Infectious Diseases, vol. 204, pp. 1532 - 1540,
http://dx.doi.org/10.1093/infdis/jir5592011
Suzuki K; Ishida T; Yamagishi M; Ahlenstiel C; Swaminathan S; Marks K; Murray D; McCartney EM; Beard MR; Alexander M; Purcell DF; Cooper DA; Watanabe T; Kelleher AD, 2011, 'Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific.', RNA biology, vol. 8, pp. 1035 - 1046
2011
Brockman M; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Atfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM, 2010, 'Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection',
Journal of Virology, vol. 84, pp. 11937 - 11949,
http://dx.doi.org/10.1128/JVI.01086-102010
Pett SL; Zaunders J; Bailey M; Murray JM; Macrae K; Emery S; Cooper DA; Kelleher AD, 2010, 'A novel Chemokine-Receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infection',
AIDS Research and Human Retroviruses, vol. 26, pp. 653 - 661,
http://dx.doi.org/10.1089/aid.2009.02782010
French MA; Tanaskovic S; Law MG; Lim A; Fernandez S; Ward LD; Kelleher AD; Emery S, 2010, 'Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high-affinity' FcγRIIa genotype',
AIDS, vol. 24, pp. 1983 - 1990,
http://dx.doi.org/10.1097/QAD.0b013e32833c1ce02010
Miura T; Brumme ZL; Brockman MA; Rosato P; Sela J; Brumme CJ; Pereyra F; Kaufmann DE; Trocha A; Block BL; Daar ES; Connick E; Jessen H; Kelleher AD; Rosenberg E; Markowitz M; Schafer K; Vaida F; Iwamoto A; Little S; Walker BD, 2010, 'Impaired replication capacity of acute/early viruses in persons who become HIV controllers',
Journal of Virology, vol. 84, pp. 7581 - 7591,
http://dx.doi.org/10.1128/JVI.00286-102010
Arnott A; Jardine D; Wilson K; Gorry P; Merlin K; Grey PA; Law MG; Dax E; Kelleher AD; Smith DE; Mcphee D, 2010, 'High viral fitness during acute HIV-1 infection',
PLoS One, vol. 5, pp. e12631,
http://dx.doi.org/10.1371/journal.pone.00126312010
Yamagishi M; Ishida T; Miyake A; Cooper DA; Kelleher AD; Suzuki K; Watanabe T, 2009, 'Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription',
Microbes and Infection, vol. 11, pp. 500 - 508,
http://dx.doi.org/10.1016/j.micinf.2009.02.0032009
Streeck H; Jolin J; Qi YC; Yassine-Diab B; Johnson ; Kwon D; Addo M; Brumme C; Routy J; Little S; Jessen H; Kelleher AD; Hecht FM; Sekaly R; Rosenberg E; Walker BD; Carrington M; Altfeld M, 2009, 'Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells',
Journal of Virology, vol. 83, pp. 7641 - 7648,
http://dx.doi.org/10.1128/JVI.00182-092009
Munier CM; Zaunders J; Ip S; Cooper DA; Kelleher AD, 2009, 'A culture amplified multi-parametric intracellular cytokine assay (CAMP-ICC) for enhanced detection of antigen specific T-cell responses',
Journal of Immunological Methods, vol. 345, pp. 1 - 16,
http://dx.doi.org/10.1016/j.jim.2009.03.0132009
Hamilton AR; Kelleher AD; Marriott D, 2009, 'Unusual association of diseases/symptoms: A case of severe visceral leishmaniasis resulting from travel to Greece',
BMJ Case Reports,
http://dx.doi.org/10.1136/bcr.06.2009.20362009
Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA, 2009, 'Evolution of CD4+T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression',
AIDS Research and Human Retroviruses, vol. 25, pp. 569 - 576,
http://dx.doi.org/10.1089/aid.2008.01492009
Zaunders J; Munier ML; Seddiki N; Pett SL; Ip S; Bailey M; Xu Y; Brown KJ; Dyer W; Kim MS; De Rose R; Kent SJ; Jiang L; Breit SN; Emery S; Cunningham AL; Cooper DA; Kelleher AD, 2009, 'High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40)',
Journal of Immunology, vol. 183, pp. 2827 - 2836,
http://dx.doi.org/10.4049/jimmunol.08035482009
Swaminathan S; Zaunders J; Wilkinson J; Suzuki K; Kelleher AD, 2009, 'Does the presence of anti-HIV miRNAs in monocytes explain their resistance to HIV-1 infection?',
Blood, vol. 113, pp. 5029 - 5030,
http://dx.doi.org/10.1182/blood-2009-01-1967412009
Venturi V; Chin HY; Asher TE; Ladell K; Scheinberg P; Bornstein E; Van Bockel D; Kelleher AD; Douek DC; Price DA; Davenport MP, 2009, 'TCR β-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV', Journal of Immunology, vol. 181, pp. 7853 - 7862
2009
Matthews PM; Leslie A; Katzourakis A; Crawford H; Payne R; Prendergast A; Power KA; Kelleher AD; Klenerman P; Carlson J; Heckerman D; Ndung''u T; Walker BD; Allen TM; Pybus O; Goulder PJ, 2009, 'HLA Footprints on human immunodeficiency virus tp 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering',
Journal of Virology, vol. 83, pp. 4605 - 4615,
http://dx.doi.org/10.1128/JVI.02017-082009
Seddiki N; Sasson SC; Santner-Nanan B; Munier M; Van Bockel DJ; Ip S; Marriott D; Pett SL; Nanan R; Cooper DA; Zaunders J; Kelleher AD, 2009, 'Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease',
European Journal of Immunology, vol. 39, pp. 391 - 403,
http://dx.doi.org/10.1002/eji.2008386302009
Schneidewind A; Brumme Z; Brumme C; Power KA; Reyor L; O Sullivan K; Gladden A; Hempel U; Kuntzen T; Wang YE; Oniangue-Ndza C; Jessen H; Markowitz M; Rosenberg E; Sekaly R; Kelleher AD; Walker BD; Allen TM, 2009, 'Transmission and long-term stability of compensated CD8 escape mutations',
Journal of Virology, vol. 83, pp. 3993 - 3997,
http://dx.doi.org/10.1128/JVI.01108-082009
Matthews PM; Leslie A; Katzourakis A; Crawford H; Payne R; Prendergast A; Power KA; Kelleher AD; Klenerman P; Carlson J; Heckerman D; Ndung''u T; Walker BD; Allen TM; Pybus O; Goulder PJ, 2009, 'HLA Footprints on Human Immunodeficiency Virus Type 1 Are Associated with Interclade Polymorphisms and Intraclade Phylogenetic Clustering',
Journal of Virology, vol. 83, pp. 4605 - 4615,
http://jvi.asm.org/content/85/9/46352009
Reddy SMR; Center RJ; Suzuki K; Gorry P; Kelleher A; Purcell DF, 2009, 'P12-01. Construction and characterization of recombinant envelope glycoproteins derived from HIV-1 pre-seroconversion strains as potential vaccine immunogens',
Retrovirology, vol. 6,
http://dx.doi.org/10.1186/1742-4690-6-S3-P1672009
De Rose R; Mason RS; Loh L; Peut V; Smith MZ; Fernandez CS; Alcantara S; amarasena T; Reece J; Seddiki N; Kelleher AD; Zaunders J; Kent SJ, 2008, 'Safety, immunogenicity and efficacy of peptide-pulsed cellular immunotherapy in macaques.',
Journal of Medical Primatology, vol. 37, pp. 69 - 78,
http://dx.doi.org/10.1111/j.1600-0684.2008.00329.x2008
Seddiki N; Kelleher AD, 2008, 'Regulatory T cell abnormalities are associated with aberrant CD4+ T cell responses in patients with immune inflammatory syndrome (IRIS)',
Clinical Immunology, vol. 127, pp. S126 - S127,
http://dx.doi.org/10.1016/j.ctim.2008.03.3592008
Lim H; Suzuki K; Cooper DA; Kelleher AD, 2008, 'Promoter-targeted siRNAs induce gene silencing of simian immunodeficiency virus (SIV) infection in vitro',
Molecular Therapy, vol. 16, pp. 565 - 570,
http://dx.doi.org/10.1038/sj.mt.63003802008
Suzuki K; Juelich T; Lim H; Ishida T; Watanebe T; Cooper DA; Rao S; Kelleher AD, 2008, 'Closed chromatin architecture is induced by an RNA duplex targeting the HIV-1 promoter region',
The Journal of Biological Chemistry, vol. 283, pp. 23353 - 23363,
http://dx.doi.org/10.1074/jbc.M7096512002008
Jarrin I; Geskus R; Bhaskaran K; Prins M; Perez-Hoyos S; Muga R; Hernández-Aguado I; Meyer L; Porter K; Amo JD; Bucher H; Chêne G; Pillay D; Rosinska M; Sabin C; Touloumi G; del Amo J; Meyer L; Rosinska M; Porter K; Walker S; Babiker A; Darbyshire J; de Luca A; Fisher M; Goujard C; Kaldor J; Kelleher T; Gelgor L; Ramacciotti T; Cooper D; Smith D; Gill J; Bruun Jørgensen L; Nielsen C; Pedersen C; Lutsar I; Dabis F; Thiebaut R; Masquelier B; Costagliola D; Vanhems P; Meyer L; Boufassa F; Hamouda O; Kucherer C; Pantazis N; Hatzakis A; Paraskevis D; Karafoulidou A; Rezza G; Dorrucci M; Longo B; Balotta C; van Asten L; van der Bij A; Coutinho R; Sannes M; Brubakk O; Eskild A; Bruun JN; Camacho R; Smolskaya T; Tor J; de Olalla PG; Caylà J; del Romero J; Pérez-Hoyos S; Hernandez Aguado I; Belda J; Rickenbach M; Francioli P; Malyuta R; Brettle R; Delpech V; Lattimore S; Murphy G; Parry J; Gill N; Lee C; Porter K; Johnson A, 2008, 'Gender differences in HIV progression to AIDS and death in industrialized countries: Slower disease progression following HIV seroconversion in women',
American Journal of Epidemiology, vol. 168, pp. 532 - 540,
http://dx.doi.org/10.1093/aje/kwn1792008
Santner-Nanan B; Seddiki N; Zhu E; Quent V; Kelleher AD; Fazekas de St Groth B; Nanan R, 2008, 'Accelerated age-dependent transition of human regulatory T cells to effector memory phenotype',
International Immunology, vol. 20, pp. 375 - 383,
http://dx.doi.org/10.1093/intimm/dxm1512008
Mallon PW; Sedwell R; Rogers GJ; Nolan D; Unemori P; Hoy JF; Samaras K; Kelleher AD; Emery S; Cooper DA; Carr AD, 2008, 'Effect of Rosiglitazone on Peroxisome Proliferator-Activated Receptor gamma Gene Expression in Human Adipose Tissue Is Limited by Antiretroviral Drug-Induced Mitochondrial Dysfunction',
Journal of Infectious Diseases, vol. 198, pp. 1794 - 1803,
http://dx.doi.org/10.1086/5931792008
Falster KA; Gelgor L; Shaik A; Zablotska Manos I; Prestage G; Grierson J; Thorpe R; Pitts M; Anderson JS; Chuah J; Mulhall BP; Petoumenos K; Kelleher AD; Law MG, 2008, 'Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment',
Sexual Health, vol. 5, pp. 141 - 154,
http://dx.doi.org/10.1071/SH070822008
Brumme Z; Brumme C; Carlson J; Streeck H; John M; Eichbaum Q; Block B; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor JM; Yuki Y; Carrington M; Allen TM; Mallal SA; Altfeld M; Heckerman D; Walker BD, 2008, 'Marked epitope- and allele- specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection',
Journal of Virology, vol. 82, pp. 9216 - 9227,
http://dx.doi.org/10.1128/JVI.01041-082008
Chessman D; Kostenko L; Lethborg T; Purcell A; Williamson N; Chen Z; Kjer-Nielsen L; Mifsud N; Tait B; Holdsworth R; Almeida C; Nolan D; Macdonalds W; Archbold J; Kelleher AD; Marriott D; Mallal SA; Bharadwaj M; Rossjohn J; McCluskey J, 2008, 'Human leukocyte antigen class I-restricted activation of CD8(+) T cells provides the immunogenetic basis of a systemic drug hypersensitivity',
Immunity, vol. 28, pp. 822 - 832,
http://dx.doi.org/10.1016/j.immuni.2008.04.0202008
Mason R; De Rose R; Seddiki N; Kelleher AD; Kent SJ, 2008, 'Low pre-infection levels and loss of central memory CD4+T cells may predict rapid progression in SIV-infected pigtail macaques',
Virology, vol. 381, pp. 11 - 15,
http://dx.doi.org/10.1016/j.virol.2008.08.0422008
Venturi V; Chin HY; Asher TE; Ladell K; Scheinberg P; Bornstein E; van Bockel D; Kelleher AD; Douek DC; Price DA; Davenport MP, 2008, 'TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV', Journal of Immunology, vol. 181, pp. 7853 - 7862
2008
Lewin S; Murray JM; Solomon A; Wightman F; Cameron P; Purcell DJ; Zaunders J; Grey PA; Bloch M; Smith DE; Cooper DA; Kelleher AD, 2008, 'Virologic determinants of success after structured treatment interruptions in antiretrovirals in acute HIV-1 infection',
JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 47, pp. 140 - 147,
http://dx.doi.org/10.1097/QAI.0b013e31815dbf7f2008
McElrath MJ; De Rosa SC; Moodie Z; Dubey S; Kierstead L; Janes H; Defawe OD; Carter DK; Hural J; Akondy R; Buchbinder SP; Robertson MN; Mehrotra DV; Self SG; Corey L; Shiver JW; Casimiro DR, 2008, 'HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis',
The Lancet, vol. 372, pp. 1894 - 1905,
http://dx.doi.org/10.1016/S0140-6736(08)61592-52008
Burton C; Goodall R; Samri A; Autran B; Kelleher AD; Poli G; Pantaleo G; Gotch F; Imami N, 2008, 'Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy',
Clinical and Experimental Immunology, vol. 152, pp. 252 - 257,
http://dx.doi.org/10.1111/j.1365-2249.2008.03611.x2008
Munier CM; Kelleher AD, 2007, 'Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection',
Immunology and Cell Biology, vol. 85, pp. 6 - 15,
http://dx.doi.org/10.1038/sj.icb.71000152007
Dyer W; Pett SL; Sullivan JS; Emery S; Cooper DA; Kelleher AD; Lloyd AR; Lewin S, 2007, 'Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples',
Clinical and Vaccine Immunology, vol. 14, pp. 52 - 59,
http://dx.doi.org/10.1128/CVI.00214-062007
Streeck H; Lichterfeld M; Alter G; Meier A; Teigen N; Yassine-Diab B; Sidhu H; Little S; Kelleher AD; Routy J; Rosenberg E; Sekaly R; Walker BD; Altfeld M, 2007, 'Recognition of a defined region within p24 Gag by CD8(+) T cells during primary human immunodeficiency virus type I infection in individuals expressing protective HLA class I alleles',
Journal of Virology, vol. 81, pp. 7725 - 7731,
http://dx.doi.org/10.1128/JVI.00708-072007
Kaufmann D; Kavanagh D; Pereyra F; Zaunders J; Mackey E; Miura T; Palmer S; Brockman M; Rathod A; Piechocka-Trocha A; Baker B; Zhu B; Le Gall S; Waring M; Ahern R; Moss K; Kelleher AD; Coffin J; Freeman G; Rosenberg E; Walker BD, 2007, 'Upregulation of CTLA-4 by HIV-specific CD4(+) T cells correlates with disease progression and defines a reversible immune dysfunction',
Nature Immunology, vol. 8, pp. 1246 - 1254,
http://dx.doi.org/10.1038/ni15152007
Emery S; Kelleher AD; Workman C; Puls R; Bloch MT; Baker D; Hoy JF; Ip S; Nalliah K; Ward L; Law MG; Cooper DA, 2007, 'Influence of IFN gamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapy',
Human Vaccines, vol. 3, pp. 260 - 267,
http://dx.doi.org/10.4161/hv.46272007
van Bockel D; Price DA; Asher TE; Venturi V; Suzuki K; Warton K; Davenport MP; Cooper DA; Douek DC; Kelleher AD, 2007, 'Validation of RNA-based molecular clonotype analysis for virus-specific CD8+ T-cells in formaldehyde-fixed specimens isolated from peripheral blood',
Journal of Immunological Methods, vol. 326, pp. 127 - 138,
http://dx.doi.org/10.1016/j.jim.2007.07.0162007
Murray JM; Emery S; Kelleher AD; Law MG; Chen J; Hazuda DJ; Nguyen BT; Teppler H; Cooper DA, 2007, 'Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase',
AIDS, vol. 21, pp. 2315 - 2321,
http://dx.doi.org/10.1097/QAD.0b013e3282f123772007
Schneidewind A; Brockman M; Yang R; Adam RI; Li B; Le Gall S; Rinaldo C; Craggs SL; Allgaier RL; Power KA; Kuntzen T; Tung C; LaBute MX; Mueller SC; Harrer T; Mcmichael AJ; Goulder PJ; Aiken CM; Brander C; Kelleher AD; Allen TM, 2007, 'Escape from the Dominant HLA-B27-Restricted Cytotoxic T-Lymphocyte Response in Gag Is Associated with a Dramatic Reduction in Human Immunodeficiency Virus Type 1 Replication',
Journal of Virology, vol. 81, pp. 12382 - 12393,
http://dx.doi.org/10.1128/JVI.01543-072007
Lin BB; Gladden A; Altfeld M; Kaldor JM; Cooper DA; Kelleher AD; Allen TM, 2007, 'Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution',
Journal of Virology, vol. 81, pp. 193 - 201,
http://dx.doi.org/10.1128/JVI.01231-062007
Samri A; Goodall RL; Burton C; Imami N; Pantaleo G; Kelleher AD; Poli G; Gotch F; Autran B, 2007, 'Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease', Antiviral Therapy, vol. 12, pp. 553 - 558
2007
Venturi V; Chin H; Asher T; Ladell K; Scheinberg P; Bornstein E; Van Bockel DJ; Kelleher AD; Douek DC; Price DA; Davenport MP, 2007, 'T cell receptor b-chain sharing in human CD8+ T cell responses to cytomegalovirus and Epstein-Barr virus', Journal of Immunology, vol. 181, pp. 7853 - 7862
2007
Zaunders J; Jing J; Leipold M; Maecker H; Kelleher AD; Koch I, 2007, 'Computationally efficient multidimensional analysis of complex flow cytometry data using second order polynomial histograms',
Cytometry Part A, vol. 89, pp. 44 - 58,
http://dx.doi.org/10.1002/cyto.a.227042007
De Rose R; Sullivan MT; Dale CJ; Kelleher AD; Emery S; Cooper DA; Ramshaw I; Boyle D; Kent SJ, 2006, 'Dose-response relationship of DNA and recombinant fowlpox virus prime-boost HIV vaccines.', Human Vaccines, vol. 2, pp. 134 - 136
2006
Fazekos de St Groth B; Seddiki N; Santner-Nanan B; Martinson J; Zaunders J; Sasson SC; Landay A; Nanan R; Kelleher AD, 2006, 'Expression of IL-2 and IL-7 receptors discriminates between human regulatory and activated T-cells within CD45RA and CD45RO compartments',
Clinical Immunology, vol. 119, pp. S7 - S7,
http://dx.doi.org/10.1016/j.clim.2006.04.0102006
Barbour J; Hecht FM; Little S; Markowitz M; Daar E; Kelleher AD; Routy J; Campbell T; Rosenberg E; Segal M; Weidler J; Grant R, 2006, 'Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacity.',
AIDS, vol. 20, pp. 2123 - 2125,
http://dx.doi.org/10.1097/01.aids.0000247583.38943.952006
Bloch MT; Smith DE; Quan D; Kaldor JM; Zaunders J; Petoumenos K; Irvine K; Law MG; Grey PA; Finlayson R; Mcfarlane R; Kelleher AD; Carr AD; Cooper DA, 2006, 'The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection: Final results from a randomized clinical trial (Pulse)',
JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 42, pp. 192 - 202,
http://dx.doi.org/10.1097/01.qai.0000219779.50668.e62006
Kelleher AD; Zaunders J, 2006, 'Decimated or missing in action:CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection. Curr HIV/AIDS Rep 2006;3(1):5-12.', Current HIV/AIDS Reports, vol. 3, pp. 5 - 12
2006
Kelleher AD; Zaunders JJ, 2006, 'Decimated or missing in action: CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection',
Current HIV/AIDS Reports, vol. 3, pp. 5 - 12,
http://dx.doi.org/10.1007/s11904-006-0002-52006
Hales GP; Birch C; Crowe S; Workman C; Hoy JF; Kelleher AD; Lincoln D; Lincoln D; Law MG; Emery S, 2006, 'A randomised trial comparing genotypic and virtual phenotypic interpretation of HIV drug resistance: The CREST study.',
PLoS Clinical Trials, vol. 1, pp. e18,
http://dx.doi.org/10.1371/journal.pctr.00100182006
Seddiki N; Santner-Nanan B; Martinson J; Zaunders J; Sasson SC; Landay A; Solomon MJ; Selby W; Alexander S; Nanan R; Kelleher AD; Fazekas de St Groth B, 2006, 'Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells',
Journal of Experimental Medicine, vol. 203, pp. 1693 - 1700,
http://dx.doi.org/10.1084/jem.200604682006
Sasson SC; Zaunders J; Zanetti G; King E; Merlin K; Smith DE; Stanley K; Cooper DA; Kelleher AD, 2006, 'Increased plasma interleukin-7 level correlates with decreased CD127 and increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection',
Journal of Infectious Diseases, vol. 193, pp. 505 - 514,
http://dx.doi.org/10.1086/4993092006
Sasson SC; Zaunders J; Kelleher AD, 2006, 'The IL-7/IL-7 receptor axis: understanding its central role in T-cell homeostatis and the challenges facing its utilization as a novel therapy. 2006;7:1571-1582.',
Current Drug Targets, vol. 7, pp. 1571 - 1582,
http://dx.doi.org/10.2174/1389450067790253652006
Zaunders J; Ip S; Munier CM; Munier M; Kaufmann D; Suzuki K; Brereton C; Seddiki N; Sasson SC; Koelsch KK; Landay A; Grey PA; Finlayson R; Kaldor JM; Rosenberg E; Walker BD; Fazekas de St Groth B; Cooper DA; Kelleher AD, 2006, 'Infection of CD127(+) (Interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection',
Journal of Virology, vol. 80, pp. 10162 - 10172,
http://dx.doi.org/10.1128/JVI.00249-062006
Kelleher AD; Puls R; Bebbington M; Boyle D; Kent S; Kippax SC; Purcell D; Thomson S; Wand HC; Cooper DA; Emery S; Ffrench RA, 2006, 'A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1',
AIDS, vol. 20, pp. 294 - 297,
http://dx.doi.org/10.1097/01.aids.0000199819.40079.e92006
Zaunders J; Dyer W; Munier CM; Ip S; Liu J; Amyes E; Rawlinson WD; Rose RJ; Kent SJ; Sullivan JS; Cooper DA; Kelleher AD, 2006, 'CD127+CCR5+CD38+++CD4+ Th1 Effector Cells Are an Early Component of the Primary Immune Response to Vaccinia Virus and Precede Development of Interleukin-2+ Memory CD4+ T Cells',
Journal of Virology, vol. 80, pp. 10151 - 10161,
http://dx.doi.org/10.1128/JVI.02670-052006
Mallon PW; Unemori P; Sedwell R; Morey AL; Rafferty M; Williams KM; Chisholm DJ; Samaras K; Emery S; Kelleher AD; Cooper DA; Carr AD, 2005, 'In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA',
Journal of Infectious Diseases, vol. 191, pp. 1686 - 1696,
http://dx.doi.org/10.1086/4296972005
Ammaranond P; Zaunders J; Satchell C; Van Bockel DJ; Cooper DA; Kelleher AD, 2005, 'A new variant cytotoxic T lymphocyte escape mutation in HLA-B27-positive individuals infected with HIV type 1',
AIDS Research and Human Retroviruses, vol. 21, pp. 395 - 397,
http://dx.doi.org/10.1089/aid.2005.21.3952005
Zaunders J; Munier M; Kaufmann D; Ip S; Grey PA; Smith DE; Ramacciotti TP; Quan D; Finlayson RJ; Kaldor JM; Rosenberg E; Walker BD; Cooper DA; Kelleher AD, 2005, 'Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection',
Blood, vol. 106, pp. 1660 - 1667,
http://dx.doi.org/10.1182/blood-2005-01-02062005
Sasson SC; Kelleher AD; Cooper DA, 2005, 'The modern ART of HIV infection management: Towards a tailored approach to maximize CD4 T cell reconstitution',
Clinical Infectious Diseases, vol. 41, pp. 373 - 375,
http://dx.doi.org/10.1086/4314892005
Mallon PW; Sedwell R; Unemori P; Kelleher AD; Cooper DA; Carr AD, 2005, 'Methodological considerations in human studies of gene expression in HIV-associated lipodystrophy', Antiviral Therapy, vol. 10, pp. M101 - M108
2005
Suzuki K; Shijuuku T; Fukamachi T; Zaunders J; Guillemin GJ; Cooper DA; Kelleher AD, 2005, 'Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region.', Journal of RNAi and Gene Silencing, vol. 1, pp. 66 - 78
2005
Emery S; Workman C; Puls R; Bloch M; Baker D; Bodsworth NJ; Anderson JA; Crowe SM; Hoy JF; Aichelburg A; Ward LA; Boyle D; Law MG; Kelleher AD; Cooper DA, 2005, 'Randomised, Placebo-Controlled, Phase 1/2a Evaluation of the Safety and Immunogenicity of Fowlpox Virus Expressing HIV gag-pol and Interferon-y in HIV-1 Infected Subjects',
Human Vaccines, vol. 1, pp. 232 - 238,
http://dx.doi.org/10.4161/hv.1.6.23422005
Furutsuki T; Hosoya N; Kawana-Tachikawa A; Tomizawa M; Odawara T; Goto M; Kitamura Y; Nakamura T; Kelleher AD; Cooper DA; Iwamoto A, 2004, 'Frequent transmission of Cytotoxic-T-Lymphocyte escape mutants of human immunodeficiency virus type 1 in the highly HLA-A24-positive Japanese population',
Journal of Virology, vol. 78, pp. 8437 - 8445,
http://dx.doi.org/10.1128/JVI.78.16.8437-8445.20042004
Lomas M; Liauw WS; Packham D; Williams KM; Kelleher AD; Zaunders J; Ward RL, 2004, 'Phase I clinical trial of a human idiotypic p53 vaccine in patients with advanced malignancy',
Annals of Oncology, vol. 15, pp. 324 - 329,
http://dx.doi.org/10.1093/annonc/mdh0532004
Pett SL; Kelleher A, 2004, 'Antiretroviral therapy-induced immune restoration in HIV infection: A double-edged sword?',
Expert Review of Anti-Infective Therapy, vol. 2, pp. 335 - 339,
http://dx.doi.org/10.1586/14787210.2.3.3352004
Zaunders JJ; Dyer WB; Wang B; Munier ML; Miranda-Saksena M; Newton R; Moore J; Mackay CR; Cooper DA; Saksena NK; Kelleher AD, 2004, 'Identification of circulating antigen-specific CD4
+ T lymphocytes with a CCR5
+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection',
Blood, vol. 103, pp. 2238 - 2247,
http://dx.doi.org/10.1182/blood-2003-08-27652004
Zaunders J; Dyer W; Wang B; Munier M; Miranda-Saksena M; Newton R; Moore JJ; MacKay CR; Cooper DA; Saksena NK; Kelleher AD, 2004, 'Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term non-progressor and in CMV infection', Blood, vol. 8, pp. 2765 - 2765
2004
Wang B; Mikhail M; Dyer W; Zaunders J; Kelleher AD; Saksena N, 2003, 'First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection',
Virology, vol. 312, pp. 135 - 135,
http://dx.doi.org/10.1016/S0042-6822(03)00159-42003
Murray JM; Kaufmann GR; Hodgkin PD; Lewin SR; Kelleher AD; Davenport MP; Zaunders JJ, 2003, 'Naive T cells maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty',
Immunology and Cell Biology, vol. 81, pp. 487 - 495,
http://dx.doi.org/10.1046/j.1440-1711.2003.01191.x2003
Ammaranond P; Cunningham PH; Oelrichs RB; Suzuki K; Harris C; Leas L; Grulich AE; Cooper DA; Kelleher AD; Harris C, 2003, 'No increase in protease resistance and a decrease in reverse transcriptase resistance mutations in primary HIV-1 infection: 1992-2001',
AIDS, vol. 17, pp. 264 - 267,
http://dx.doi.org/10.1097/00002030-200301240-000202003
Pett SL; Kelleher AD, 2003, 'Cytokine therapies in HIV-1 infection: present and future', Expert Review of Anti-Infective Therapy, vol. 1, pp. 89 - 102
2003
Ammaranond P; Cunningham PH; Oelrichs RB; Suzuki K; Harris C; Leas L; Grulich AE; Cooper DA; Kelleher AD; Harris C, 2003, 'Rates of transmission of antiretroviral drug resistant strains of HIV-1',
Journal of Clinical Virology, vol. 26, pp. 153 - 153,
http://dx.doi.org/10.1016/S1386-6532(02)00114-22003
Zaunders J; Moutouh-de Parseval L; Kitada S; Reed JC; Rought S; Genini D; Leoni L; Kelleher AD; Cooper DA; Smith DE; Grey PA; Estaquier J; Little S; Richman DD; Corbeil J, 2003, 'Polyclonal proliferation and apoptosis of CCR5+ T Lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2',
Journal of Infectious Diseases, vol. 187, pp. 1735 - 1735,
http://dx.doi.org/10.1086/3750302003
Wang B; Dyer W; Zaunders J; Mikhail M; Sullivan JS; Haddad DM; Williams LA; Harris G; Holt J; Cooper DA; Miranda-Saksena M; Boadle R; Kelleher AD; Saksena NK, 2002, 'Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infection',
Virology, vol. 304, pp. 246 - 264,
http://dx.doi.org/10.1006/viro.2002.17062002
Kelleher AD; Sewell AK; Price DA, 2002, 'Dyslipidemia due to retroviral protease inhibitors [2] (multiple letters)', Nature Medicine, vol. 8, pp. 308 - 309
2002
Cunliffe S; Wyer JR; Sutton J; Lucas M; Harcourt G; Klenerman P; Mcmichael AJ; Kelleher AD, 2002, 'Optimization of peptide linker length in production of MHC Class II/peptide tetrameric complexes increases yield, stability and allows identification of antigen specific CD4+ T cells in PBMC',
European Journal of Immunology, vol. 32, pp. 3366 - 3375,
http://dx.doi.org/10.1002/1521-4141(200212)32:12<3366::AID-IMMU3366>3.0.CO;2-#2002
Allen TM; Kelleher AD; Zaunders J; Walker BD, 2002, 'Supervised or structured treatment interruption (STI) and beyond...', Biofutur, pp. 52 - 58
2002
Appay V; Zaunders J; Papagno L; Sutton J; Jaramillo AB; Waters A; Eastbrook P; Grey PA; Smith DE; Mcmichael AJ; Cooper DA; Rowland-Jones SL; Kelleher AD, 2002, 'Characterization of CD4(+) CTLs ex vivo',
Journal of Immunology, vol. 168, pp. 5954 - 5958,
http://dx.doi.org/10.4049/jimmunol.168.11.59542002
Kelleher AD; Long C; Holmes EC; Allen RL; Wilson J; Conlon C; Workman C; Shaunak S; Olson K; Goulder P; Brander C; Ogg G; Sullivan JS; Dyer W; Jones I; McMichael AJ; Rowland-Jones S; Phillips RE, 2001, 'Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses',
Journal of Experimental Medicine, vol. 193, pp. 375 - 385,
http://dx.doi.org/10.1084/jem.193.3.3752001
Kelleher AD; Booth JL; Sewell AK; Oxenius A; Cerundolo V; McMichael AJ; Phillips RE; Price DA, 2001, 'Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes',
AIDS Research and Human Retroviruses, vol. 17, pp. 1063 - 1066,
http://dx.doi.org/10.1089/0889222013003437442001
Kaufmann GR; Zaunders J; Murray JM; Kelleher AD; Lewin S; Solomon A; Smith DE; Cooper DA, 2001, 'Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modelling.',
AIDS Research and Human Retroviruses, vol. 17, pp. 147 - 159,
http://dx.doi.org/10.1089/088922201502172382001
Suzuki K; Cunningham P; Harris C; Leas L; Zaunders J; Cooper DA; Kaufmann GR; Pett SL; Kelleher A; Mukaide M; Imai M; Kondo M; Finlayson R, 2001, 'Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine',
AIDS Research and Human Retroviruses, vol. 17, pp. 1293 - 1296,
http://dx.doi.org/10.1089/0889222017504613662001
Oxenius A; Price DA; Easterbrook PJ; O'Callaghan CA; Kelleher AD; Whelan JA; Sontag G; Sewell AK; Phillips RE, 2000, 'Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8
+ and CD4
+ T lymphocytes',
Proceedings of the National Academy of Sciences of the United States of America, vol. 97, pp. 3382 - 3387,
http://dx.doi.org/10.1073/pnas.97.7.33822000
Sewell AK; Price DA; Oxenius A; Kelleher AD; Phillips RE, 2000, 'Cytotoxic T lymphocyte responses to human immunodeficiency virus: Control and escape',
Stem Cells, vol. 18, pp. 230 - 244,
http://dx.doi.org/10.1634/stemcells.18-4-2302000
McMichael AJ; Ogg G; Wilson J; Callan M; Hambleton S; Appay V; Kelleher T; Rowland-Jones S, 2000, 'Memory CD8
+ T cells in HIV infection',
Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 355, pp. 363 - 367,
http://dx.doi.org/10.1098/rstb.2000.05752000
Kaufmann GR; Zaunders J; Kelleher AD; Grey PA; Smith DE; Carr AD; Cooper DA, 2000, 'Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection',
AIDS, vol. 14, pp. 2543 - 2551,
http://dx.doi.org/10.1097/00002030-200012010-000032000
Kelleher AD; Sewell WA; Cooper DA, 1999, 'Effect of protease therapy on cytokine secretion by peripheral blood mononuclear cells (PBMC) from HIV-infected subjects',
Clinical and Experimental Immunology, vol. 115, pp. 147 - 152,
http://dx.doi.org/10.1046/j.1365-2249.1999.00761.x1999
McMichael AJ; Kelleher A, 1999, 'The arrival of HLA class II tetramers', Journal of Clinical Investigation, vol. 104, pp. 1669 - 1770
1999
Zaunders J; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright RH; Smith DE; Grey PA; Vizzard J; Carr AD; Cooper DA, 1999, 'Potent antiretroviral therapy of primary HIV-1 infection: partial normalisation of T lympho-cyte subsets and limited reduction of proviral DNA despite clearance of plasma viremia.',
Journal of Infectious Diseases, vol. 180, pp. 320 - 329,
http://dx.doi.org/10.1086/3148801999
Benson EM; Clarkson J; Law MG; Marshall ; Kelleher AD; Smith DE; Patou G; Stewart GA; Cooper DA; Ffrench FA, 1999, 'Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific CTL activity in asymptomatic HIV infected individuals.',
AIDS Research and Human Retroviruses, vol. 15, pp. 105 - 113,
http://dx.doi.org/10.1089/0889222993115381999
Kelleher AD; Roggensack M; Jaramillo AB; Smith DE; Walker AC; Gow I; Mcmurchie M; Harris JA; Patou G; Cooper DA; Duncombe CJ; Bloch M; Quan D; Beveridge A; Genn B; Pethebridge A; Todhunter L; Baker D; Mcfarlane R; Mindel A; Knox J; O Connor C; Mitchell JR; Meese P; Chenworth I; Anderson JS; Roth N, 1998, 'Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects',
AIDS, vol. 12, pp. 175 - 182,
http://dx.doi.org/10.1097/00002030-199802000-000071998
Kelleher AD; Roggensack M; Emery S; Carr AD; French MA; Cooper DA, 1998, 'Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens',
Clinical and Experimental Immunology, vol. 113, pp. 85 - 91,
http://dx.doi.org/10.1046/j.1365-2249.1998.00633.x1998
Kaufmann GR; Cunningham PH; Kelleher AD; Zaunders J; Carr AD; Vizzard J; Law MG; Cooper DA; Catchpole BR; Baker D; Beveridge A; Bloch M; Byrne J; Doong N; Duncombe CJ; Finlayson R; Genn W; Kidd J; Mcfarlane R; Mcmurchie M; Mcnulty A; Pethebridge A; Quan D; Robertson M, 1998, 'Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection',
Journal of Infectious Diseases, vol. 178, pp. 1812 - 1815,
http://dx.doi.org/10.1086/3144801998
Wilson JDK; Ogg GS; Allen RL; Goulder PJR; Kelleher A; Sewell AK; O'Callaghan CA; Rowland-Jones SL; Callan MFC; McMichael AJ, 1998, 'Oligoclonal expansions of CD8
+ T cells in chronic HIV infection are antigen specific',
Journal of Experimental Medicine, vol. 188, pp. 785 - 790,
http://dx.doi.org/10.1084/jem.188.4.7851998
Kelleher AD; Al-Harthi L; Landay AL, 1997, 'Immunological effects of antiretroviral and immune therapies for HIV.', AIDS (London, England), vol. 11 Suppl A
1997
Kelleher S; Emery S; Cunningham PH; Duncombe CJ; Carr AD; Golding H; Forde S; Hudson J; Roggensack M; Forrest BD; Cooper DA, 1997, 'Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injection',
AIDS Research and Human Retroviruses, vol. 13, pp. 29 - 32,
http://dx.doi.org/10.1089/aid.1997.13.291997
Kelleher AD; Carr AD; Zaunders J; Cooper DA, 1996, 'Alterations in the immune response of HIV-infected subjects treated with an HIV specific protease inhibitor, ritonavir',
Journal of Infectious Diseases, vol. 173, pp. 321 - 329,
http://dx.doi.org/10.1093/infdis/173.2.3211996
Kelleher AD; Orth D, 1996, 'Early HIV-induced immune deficiency', Medical Journal of Australia, vol. 164, pp. 107 - 108
1996
Kelleher AD; Orth D, 1996, 'Managing HIV:early HIV induced immune deficiency', Medical Journal of Australia, vol. 164, pp. 107 - 108
1996
Carr AD; Emery S; Kelleher AD; Law MG; Cooper DA, 1996, 'CD8+ lymphocyte responses to antiretroviral therapy of HIV infection',
Journal of acquired immune deficiency syndrome and human retrovirology, vol. 13, pp. 320 - 326,
http://dx.doi.org/10.1097/00042560-199612010-000041996
Stewart GJ; Irvine SS; Scott M; Kelleher AD; Marriott DJ; McKnight I; Pethebridge AM; Wodak A; Ziegler J, 1996, 'Managing HIV. Part 1: Principles. 1.2 Strategies of care in managing HIV.', The Medical journal of Australia, vol. 164, pp. 99 - 104
1996
Kelleher AD; Brew BJ; Milliken ST, 1994, 'Intractable headache as the presenting complaint of AIDS-related lymphoma confined to bone', Journal of Acquired Immune Deficiency Syndromes, vol. 7, pp. 629 - 630
1994
Quinn D; Pocock N; Freund J; Kelleher A; Penny R; Brew B, 1993, 'Radionuclide hepatobiliary scanning in patients with AIDS-related sclerosing cholangitis',
Clinical Nuclear Medicine, vol. 18, pp. 417 - 422,
http://dx.doi.org/10.1097/00003072-199305000-000101993
Nasr N; Alshehri AA; Wright TK; Shahid M; Heiner BM; Harman AN; Botting RA; Helbig K; Kelleher AD; Suzuki K; Beard M; Hertzog P; Cunningham AL, 2016, 'HIV induces interferon stimulated genes in two phases in macrophages while inhibiting interferon induction', in
EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, Melbourne, AUSTRALIA, pp. 630 - 630, presented at International Congress of Immunology (ICI), Melbourne, AUSTRALIA, 21 August 2016 - 26 August 2016,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610401456&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d12016
Worley M; Kelleher AD; Kent SJ; Chung AW, 2016, 'Neutrophils mediate potent and rapid anti-HIV antibody-dependent functions', in
EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, Melbourne, AUSTRALIA, pp. 73 - 74, presented at International Congress of Immunology (ICI), Melbourne, AUSTRALIA, 21 August 2016 - 26 August 2016,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610400147&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d12016
Wines BD; Vanderven HA; Esparon S; Madhavi V; Center RJ; Kristensen AB; Gonelli CA; Poumbourios A; Parsons M; Emery S; Kelleher A; Purcell DFJ; Kent SJ; Hogarth PM, 2016, 'Fc gamma R ectodomain probes measure anti-viral IgG effector function', in
EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, Melbourne, AUSTRALIA, pp. 1256 - 1257, presented at International Congress of Immunology (ICI), Melbourne, AUSTRALIA, 21 August 2016 - 26 August 2016,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000391563600040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d12016
Madhavi V; Wines B; Emery S; Amin J; Kelleher A; Hogarth M; Stratov I; Kent S, 2016, '"HIV-1 controllers" - what's their secret?', in
EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, Melbourne, AUSTRALIA, pp. 74 - 74, presented at International Congress of Immunology (ICI), Melbourne, AUSTRALIA, 21 August 2016 - 26 August 2016,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610400148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d12016
Pham QD; Wilson DP; Law M; Kelleher A; Zhang L, 2014, 'Transmission modes of HIV and risk of infection of antiretroviral resistance among treatment-naive HIV-infected people: a global systematic review and meta-analysis', in
ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Berlin, GERMANY, pp. A65 - A65, presented at International Workshop on Antiviral Drug Resistance - Meeting the Global Challenge, Berlin, GERMANY, 03 June 2014 - 07 June 2014,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354380300059&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d12014
Kramski M; Madhavi V; Jegaskanda S; Center RJ; Batiz FEAS; Ananworanich J; Cooper D; Kelleher A; Hsu D; Kent SJ, 2013, 'Decreased HIV-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Infected Subjects on cART: Implications for Therapeutic Vaccines', in
AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT, INC, Barcelona, SPAIN, pp. A52 - A53, presented at Conference on AIDS Vaccine, Barcelona, SPAIN, 07 October 2013 - 10 October 2013,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326037500128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d12013
Achhra AC; Boyd M; Law MG; Matthews G; Kelleher AD; Cooper DA, 2013, 'Sequencing antiretroviral therapy to maximize patient safety: could we move away from ritonavir, abacavir, tenofovir and efavirenz (RATE) - agents that concern prescribers and patients? A feasibility study and call for a trial', in
ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Brussels, BELGIUM, pp. A51 - A51, presented at 15th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, Brussels, BELGIUM, 15 October 2013 - 17 October 2013,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335230200056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d12013
Land S; Tu E; Swenson L; Kelleher A; Kaye S; Pett SL; Emery S; Kaiser R; Silk D; Berthon-Jones N; Harrigan PR, 2013, 'Proviral DNA testing of HIV tropism in the Maraviroc Switch Collaborative Study (MARCH) - results of a three-phase quality assurance (QA) programme', in
ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Toronto, CANADA, pp. A144 - A144, presented at International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, Toronto, CANADA, 04 June 2013 - 08 June 2013,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335229500117&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d12013
Kuang X; Le A; Mwimanzi P; Anmole G; Ueno T; Miura T; Connick E; Daar ES; Kelleher A; Jessen H; Little S; Markowitz M; Pereyra F; Rosenberg E; Walker B; Brumme Z; Brockman M, 2013, 'Impaired Early HIV-1 Nef Function in Spontaneous Viremic Controllers', in
AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT, INC, Barcelona, SPAIN, pp. A83 - A84, presented at Conference on AIDS Vaccine, Barcelona, SPAIN, 07 October 2013 - 10 October 2013,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326037500210&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d12013
Suzuki K; Swaminathan S; Hood C; Cooper DA; Watanebe T; Kelleher AD, 2011, 'SEQUENCE SPECIFIC INDUCTION OF HIV-1 TRANSCRIPTIONAL GENE SILENCING TARGETING NF-kappa B SEQUENCES BY SIRNA WITHOUT ANY OFF-TARGET EFFECTS OF OTHER NF-kappa B DRIVEN GENES', in
JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, Univ Melbourne, Bio21 Inst, Parkville, AUSTRALIA, pp. 425 - 425, presented at 7th Biennial Meeting of the Australasian-Gene-Therapy-Society, Univ Melbourne, Bio21 Inst, Parkville, AUSTRALIA, 04 May 2011 - 06 May 2011,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297950900031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d12011
Munier CM; Bailey MR; Xu Y; Liu S; Cooper DA; Zaunders J; Kent SJ; Kelleher AD, 2011, 'Primary Immune Responses to Vaccinia Virus Vaccination: The Role of Cytotoxic Effector CD4+ T Cells in the Generation of Human T Cell Memory', in
AIDS Research and Human Retroviruses, Mary Ann Liebert Inc, Bangkok, THAILAND, pp. A129 - A139, presented at Conference on AIDS Vaccine, Bangkok, THAILAND, 12 September 2011 - 15 September 2011,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295790500334&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a2011
Namasivayam M; Zaunders J; Ip S; Scott GM; Shaw P; Trahair TN; O''brien T; Rawlinson WD; Walls T; Kelleher AD; Ziegler JB, 2011, 'Performance of quantiferon-cmv (r) and whole-blood cd4(+)cd25(+)cd134(+) assays in identification of human cytomegalovirus-specific t-cells in children post-haematopoietic stem cell transplantation', in
Internal Medicine Journal, Blackwell Publishing Asia, pp. 12 - 12,
http://dx.doi.org/10.1111/%28ISSN%291445-59942011
Koelsch KK; Xu Y; Bailey M; McBride K; Seddiki N; Suzuki K; Murray J; Cooper DA; Kelleher AD; Zaunders J, 2010, 'Most HIV DNA in PBMC is present in non-gut-homing, resting central memory CD4 T-cells', in
ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Dubrovnik, CROATIA, pp. A44 - A44, presented at International HIV and Hepatitis Virus Drug Resistance and Curative Strategies Workshop, Dubrovnik, CROATIA, 08 June 2010 - 12 June 2010,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431300040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a2010
Koelsch KK; Xu Y; Bailey M; McBride K; Seddiki N; Suzuki K; Murray J; Cooper DA; Kelleher AD; Zaunders J, 2010, 'Most HIV DNA in PBMC is present in non-gut-homing, resting central memory CD4 T-cells.', in
ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Dubrovnik, CROATIA, pp. A44 - A44, presented at International HIV and Hepatitis Virus Drug Resistance and Curative Strategies Workshop, Dubrovnik, CROATIA, 08 June 2010 - 12 June 2010,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000280215800055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d12010
Distler O; Mallon PW; Kelleher AD; Carr A; Calmy A; Cooper DA, 2009, 'Evaluation of adipose gene expression and mitochondrial DNA in healthy adults over a 6 week course of NRTI and/or PI treatment. Indications of divergent effects', in
ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Philadelphia, PA, pp. A10 - A11, presented at 11th International Workshop on AdverseDrug Reactions and Co-Morbidities in HIV, Philadelphia, PA, 26 October 2009 - 28 October 2009,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000272060000029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d12009
Streeck H; Jolin J; Yassine-Diab B; Qi YC; Kwon D; Addo M; Brumme C; Routy J; Little SE; Jessen H; Kelleher AD; Sekaly R; Rosenberg E; Walker BD; Carrington M; Altfeld M, 2008, 'Early CD8+T Cell Responses are the Major Contributors to the Later Viral Set Point', in
AIDS Research and Human Retroviruses, Mary Ann Liebert Inc, Larchmont, NY, USA, pp. 7 - 7, presented at AIDS Research and Human Retroviruses, Cape Town, SOUTH AFRICA,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000260530800014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a2008
Schneidewind A; Brumme Z; Brume C; Power KA; Reyor L; O Sullivan K; Jessen H; Markowitz M; Rosenberg E; Sekaly R; Kelleher AD; Walker BD; Allen TM, 2008, 'Long-term Stability of Compensated CTL Escape Mutations following Acute HIV Infection', in
AIDS Research and Human Retroviruses, Mary Ann Liebert Inc, Larchmont, NY, USA, pp. 78 - 78, presented at AIDS Research and Human Retroviruses, Cape Town, SOUTH AFRICA,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000260530800195&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a2008
Brumme C; Brumme Z; Carlson J; Markowitz M; Jessen H; Kelleher AD; John M; Mallal SS; Allen T; Heckerman D; Walker BD, 2008, 'Reversion of HLA-Associated Polymorphisms in Gag, Pol and Nef during the First Year of HIV Infection: Sites, Rates and pVL Correlations', in
AIDS Research and Human Retroviruses, Mary Ann Liebert Inc, Larchmont, NY, USA, pp. 76 - 77, presented at AIDS Research and Human Retroviruses, Cape Town, SOUTH AFRICA,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000260530800190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a2008
Buchbinder SP; Mehrotra DV; Duerr A; Fitzgerald DW; Mogg R; Li D; Gilbert PB; Lama JR; Marmor M; del Rio C; McElrath MJ; Casimiro DR; Gottesdiener KM; Chodakewitz JA; Corey L; Robertson MN, 2008, 'Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial', in
The Lancet, pp. 1881 - 1893,
http://dx.doi.org/10.1016/S0140-6736(08)61591-32008
Zaunders J; Dyer W; Munier CM; Ip S; Rawlinson WD; Sullivan JS; Cooper DA; Kelleher AD, 2006, 'Transient CCR5+ CD38+++ CD4+ effector TH1 cells are an early component of the primary immune response to vaccinia and immediately precede IL-2+ memory CD4+ T cells', in
CYTOMETRY PART A, Wiley-Liss, Queensland, AUSTRIA, pp. 400 - 400, presented at 7th Samuel A Latt Conference on Stem Cells in the Age of Fluorescence Technology, Queensland, AUSTRIA, 06 November 2005 - 09 November 2005,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000237187700019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a2006
Van Bockel DJ; Suzuki K; Warton K; Ammaranond P; Douek D; La Gruta N; Munier M; McGinley C; Nallaiah K; Stanley K; Turner SJ; Zaunders J; Cooper DA; Kelleher AD, 2005, 'TCR clonotypic analysis of CMV antigen-specific CD8+ T-cells from formaldehyde fixed peripheral blood', in
Tissue Antigens, Blackwell Munksgaard, Melbourne, AUSTRALIA, pp. 573 - 574, presented at 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, Melbourne, AUSTRALIA, 29 November 2005 - 02 December 2005,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700629&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a2005
Ip S; Zaunders JJ; Munier M; Cooper DA; Kelleher AD, 2005, 'Optimizing 9-colour analysis of gut-homing CD4+T cell subsets', in
CYTOMETRY PART A, WILEY-LISS, Queensland, AUSTRIA, pp. 400 - 400, presented at 7th Samuel A Latt Conference on Stem Cells in the Age of Fluorescence Technology, Queensland, AUSTRIA, 06 November 2005 - 09 November 2005,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000237187700020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d12005
Fazekas de St Groth B; Seddiki N; Tan S; Higgins C; Power C; Santner-Nanan B; Nanan R; Sasson S; Zaunders J; Kelleher A; Landay A, 2005, 'Regulatory T cells and the maintenance of tolerance', in
TISSUE ANTIGENS, BLACKWELL PUBLISHING, Melbourne, AUSTRALIA, pp. 412 - 412, presented at 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, Melbourne, AUSTRALIA, 29 November 2005 - 02 December 2005,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700194&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a2005
Munier M; Zaunders J; Ip S; Cooper DA; Kelleher AD, 2005, 'Development and optimisation of a culture amplified multiparametric intraceilular cytokine assay for the assessment of vaccine immunogenicity', in
Tissue Antigens, Blackwell Munksgaard, Melbourne, AUSTRALIA, pp. 499 - 499, presented at 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, Melbourne, AUSTRALIA, 29 November 2005 - 02 December 2005,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700430&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a2005
Puls R; Munier M; MCgHIE K; Chadborn I; Emery S; Kelleher AD; Law MG; Carr AD, 2003, 'HIV Lipodystrophy Case Definition Study Group. Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, pp. 57 - 57
2003
Puls R; Munier M; MCgHIE K; Chadborn I; Emery S; Kelleher AD; Law MG; Carr AD, 2003, 'Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in
Antiviral Therapy, Int Medical Press Ltd, Paris, FRANCE, pp. L73 - L73, presented at 5th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Paris, FRANCE, 08 July 2003 - 11 July 2003,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231266500130&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a2003
Mallon PWG; Munier ML; McGhie K; Zaunders J; Kelleher A; Cooper DA; Carr A, 2002, 'Disrupted expression of lipid transport genes in monocytes of individuals with HIV-associated lipodystrophy - an additional risk for cardiovascular disease?', in
ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, SAN DIEGO, CALIFORNIA, pp. L8 - L9, presented at 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, SAN DIEGO, CALIFORNIA, 22 September 2002 - 25 September 2002,
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000179501500023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d12002
Clarkson J; Ffrench FA; Law MG; Marshall ; Kelleher AD; Smith DE; Patou G; Cooper DA; Stewart GA; Benson EM, 1997, 'Therapeutic vaccination with p24-VLP and AZT augments HIV specific CTL activity in asymptomatic HIV-infected individuals.', in Australasian Society for HIV Medicine 9th Annual Conference, Australasian Society for HIV Medicine 9th Annual Conference, Adelaide, Sth Aust, presented at Australasian Society for HIV Medicine 9th Annual Conference, Adelaide, Sth Aust, 13 November 1997 - 16 November 1997
1997
Kelleher AD; Walker AC; Jaramillo AB; Roggensack M; Smith DE; Gow I; Cooper DA, 1997, 'Effect of therapeutic vaccine p24-VLP and AZT on immunological and virological markets in asymptomatic subjects', in 4th Conference on Retrovirology and Opportunistic Infections, 4th Conference on Retroviruses and Opportunistic Infections, Washington DC, USA, presented at 4th Conference on Retrovirology and Opportunistic Infections, Washington DC, USA
1997
Kelleher AD; Bloch M; Smith DE; Grey PA; Cunningham PH; Zaunders J; Cooper DA, 1997, 'Reversal of CD8 activation in patients with primary HIV infection treated with AZT, 3TC and indinavir.', in 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, presented at 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, 29 September 1997 - 01 October 1997
1997
Bloch M; Kelleher AD; Smith DE; Grey PA; Zaunders J; Cooper DA, 1997, 'CD8 activation does not totally normalise in treated primary HIV infection despite undetectable viral load; evidence for ongoing viral replication?', in 6th European Conference on Clinical Aspects and Treatment of HIV-Infection, 6th European Conference on Clinical Aspects and Treatment of HIV-Infection, Hamburg, Germany, presented at 6th European Conference on Clinical Aspects and Treatment of HIV-Infection, Hamburg, Germany, 11 October 1997 - 15 October 1997
1997
Smith DE; Bloch M; Grey PA; Cunningham PH; Zaunders J; Kelleher AD; Cooper DA, 1997, 'Reversal of lymphocyte RA/RO ratios in patients with primary HIV infection treated with zidovudine, lamivudine and indinavir.', in International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication, International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication, St Petersburg, Florida, USA, presented at International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication, St Petersburg, Florida, USA, 25 June 1997 - 29 June 1997
1997
Kelleher AD; Smith DE; Cooper DA; Walker AC; Gow I; Patou G, 1996, 'Effects of therapeutic vaccination (p24-VLP) and AZT on immunological and virological markers in asymptomatic subjects', in 3rd International Congress on Drug Therapy in HIV Infection, 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England, pp. 137 - 137, presented at 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England
1996
